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ABSTRACT 
The antioxidative and hypotensive activities of the marine macroalgae from 
Hong Kong were investigated. Thirteen species of the aqueous and methanol extracts 
of marine algae were screened for their antioxidative activities by examining 
scavenging of superoxide radical, inhibition of erythrocytes (RBC) hemolysis and 
suppression of lipid peroxidation. The aqueous extracts of marine algae had a strong 
scavenging action on superoxide radicals using phenazin methosulphate-NADH-
nitroblue tetrazolium system, but not the methanol ones. Most of the aqueous and 
methanol extracts of marine algae exhibited dose-dependent inhibition of rat RBC 
against hemolysis induced by 2,2'-azo-bis(2-amidinopropane) dihydrochloride 
(AAPH, a peroxyl radicals initiator), with a few exceptions, which were probably due 
to the presence of pro-oxidants or the toxic substances in these extracts that caused 
lysis to red blood cells at high concentration. Both the aqueous and methanol extracts 
of marine algae also showed a dose-dependent suppression effect against 
Fe^Vascorbate induced lipid peroxidation using rat brain homogenate. Most of the 
methanol extracts had more inhibition in both the hemolysis and lipid peroxidation 
assays than the aqueous extracts. The methanol extract of S. siliquastrum exhibited 
the highest potency to protect RBC and inhibit lipid peroxidation, and therefore it was 
further fractionated by differential solvent extraction into 4 sub-fractions, namely, the 
dichloromethane, ethyl acetate, butanol, and water extracts. The dichloromethane 
sub-fraction of S. siliquastrum was subsequently further fractionated into 4 sub-
fractions, F l , F2, F3 and F4 by silica gel column chromatography. All sub-fractions 
i 
contained phenolic compounds but no correlation between the antioxidant potency 
and total phenolic compound using Folin-Ciocalteau method on each fraction was 
found. The presence of phenolic compounds in the sub-fractions were further 
supported by TLC，UV spectra and IR analysis. F1 contained the highest antioxidant 
activity which was able to inhibit both RBC hemolysis and lipid peroxidation, its 
efficacy being 3 folds higher than that of BHA. Therefore, F1 probably contained 
relatively the most potent antioxidant phenolic compound(s) which is non-polar, non-
toxic, and could protect cells against hemolysis and oxidative stress. 
The hypotensive effects of the aqueous and methanol extracts of the 4 species 
of marine algae were investigated using normotensive Sprague Dawley rats. 
Intravenous injection of the aqueous and methanol extracts of angustifolium and S. 
siliquastmm, and the methanol extract of Enteromorpha sp. could lower the mean 
arterial pressure, with the aqueous extract of S. siliquastrum being the most potent 
one. However, the aqueous extract of S. siliquastrum produced tachyphylaxis and 
killed the rat at a dose of 30mg/kg. The mechanisms of the hypotensive activity of the 
algae extracts were studied using 6 different blockers, namely: autonomic ganglion 
transmission, a-adrenoceptor , p-adrenoceptor, muscarinic receptor, histaminergic 
receptor and renin-angiotensin system. Based on these pharmacological studies, both 
aqueous and methanol extracts of marine algae produced hypotensive response 
through different mechanisms of action, which implied that they probably contained a 
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1. GENERAL INTRODUCTION 
Algae generally are considered to be autotrophs, requiring only inorganic 
nutrients, such as carbon dioxide, water, phosphates, and inorganic nitrogen with light 
as an energy source. They commonly grow in aquatic environment in either fresh oi 
marine waters. They range in size from microscopic, single cells to large macrophytes 
(macroalgae). The microalgae have thalli that are too small (as small as one 
micrometer) to be seen without a microscope, whereas the macroalgae have individual 
thalli that are visible without viewing aids and may grow to over 50 meters in length 
(Darley, 1982). Macroalgae differ from land plants in that they have little or no 
supporting tissue and take up nutrients over their entire surface. 
Alga is the Latin word for seaweed. Seaweed probably evolved in the 
Precambrian, or 900 to 600 million ybp (years before present) (Dawes, 1998). 
Chapman (1970) reported that Roman ladies in the time of the Caesars used as rouge 
extracted from Fucus. The other uses were recorded as early as the fourth century on 
the use of seaweeds as a partial substitute for manure. To this day macroalgae have 
been applied in agriculture as animal feed, fertilizer, and soil conditioners. Some algae 
are also used for food and in commercial products. Actually, algae have been used as 
human food and medicine since ancient times and seaweeds were undoubtedly used in 
1 
prehistoric times. There are historical references to such uses as early as 600-800 B.C 
in China (Lobban and Wyune, 1981). 
1.1 Classification of algae 
Algae are classified into three categories: green, brown and red. They are 
classified mainly on the basis of (1) their pigment composition, (2) chemical nature of 
storage products and (3) cell wall composition. 
(a) Chlorophyta (Green algae) 
Approximately 8000 species of green algae have been described. They are 
mostly found in fresh water but some also dominate in marine and terrestrial 
environment (van den Hoek et al, 1995). They are green in colour due to 
predominance of the green pigment chlorophyll. They are chlorophyll a and b, and (3-
carotene (Dring, 1992). The most important reserve polysaccharide is starch, usually 
present as granules around pyrenoid. Three structural polysaccharides that 
predominate in the wall of green algae are cellulose, xylans and mannans (van den 
Hoek et al., 1995). Green alga is not widely utilized by human. However, some green 
algae {Ulva, Enteromorpha, Monostroma and Caulerpa) are eaten in many Asian and 
Pacific countries (Chapman, 1970). 
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(b) Phaeophyta (Brown algae) 
Brown algae are almost all marine and live attached to rocks around sea coasts 
About 1500-2000 species have been described (van den Hoek et al., 1995). They are 
brown in colour mainly attributed to an accessory pigment called fucoxanthin, which 
marks the presence of the green photosynthetic chlorophyll. They also contain 
chlorophyll a and c (Dring, 1992). The most important reserve product is laminaran, 
which is a p- l ,3- l inked glucan and lies in solution in special vacuoles. The cell walls 
consist of 3 kinds of polymer, namely alginate, cellulose and complex heteroglycans 
(Clayton and King, 1990). Physodes are a characteristic and common feature of brown 
algal cells containing phlorotannins, which are polymers of phloroglucinol. Brown 
algae are known to have antibiotic and antiviral activities (Clayton and King, 1990). 
They are used for human food especially in the Orient, and in Europe. 
(c) Rhodophyta (Red algae) 
There are approximately 5000 species of red algae, 95% of which are found in 
marine environment. They are red in colour due to the accessory photosynthetic 
pigment phycoerythrin, which is located in the chloroplasts. They also have blue-green 
pigment, phycocyanin and allophycocyanin. Therefore, some red algae e.g. Porphyra 
sp. may appear brown or olive-green (Dring, 1992). The most important storage 
product is floridean starch, an a-l，4-linked glucan. The cell wall consists of cellulose, 
xylans, mannans and several sulfated polysaccharides (galactans) (van den Hoek et al； 
1995). Red algae have the greatest economic value and been used for both food and 
industrial purposes. 
3 
1.2 Chemical and mineral composition of marine macroalge 
Marine algae contain various amounts of chemical components including 
carbohydrate, protein, fibre, fat, and mineral elements. Some of them are important 
nutrients which are used in human food. Like other flowering plants, the chemical 
composition of marine algae are varied and affected by species, habitats, maturity, and 
environmental conditions (Ito and Hori, 1989). 
Table 1.1 lists the proximate composition of some edible seaweed done by 
Robledo and Pelegrin (1997). Ash ( -55%) and carbohydrate ( -36%) were the most 
abundant constituents in Chlorophyta and Rhodophyta, respectively. However, 
carbohydrates are the most important chemical constituent in terms of commercial 
value (Ito and Hori, 1989). In general, the main polysaccharide of red algae is sulfated 
galactan, which is also named agar and carrageenan. Carbohydrate of brown algae 
consists mainly of compounds related to mannose, glucose, and alginic acid. Protein 
and lipid content of marine algae are relatively low. Norziah and Ching (2000) showed 
that the red alga Gracilaria changgi has a high composition of unsaturated fatty acids 
(740/0), mainly the omega fatty acids, eicosapentaenoic acid and decosahexanoic which 
are beneficial to human health. 
Table 1.2 lists the mineral content of some marine algae (Ito and Hori, 1989). 
All minerals required by human 一 calcium, sodium, magnesium, potassium, 
phosphorus, iodine, iron, and zinc - are present in significant amounts in marine algae. 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































1.3 Uses of marine macroalgae 
Marine macroalge have been used extensively and have important economic 
value as a source of human food, animal food, therapeutic purpose and other industrial 
uses. It is estimated that at least 221 species of seaweed are used world-wide, namely 
32 chlorophytes, 125 rhodophytes and 64 phaeophytes (Zemke-White and Ohno, 
1999). Over 2 million tons (dry weight) of seaweed was produced annually 
(worldwide) in 1994/1995 (Zemke-White and Ohno, 1999). The supply of seaweed 
has been harvested from both natural vegetation and from sites cultivated by human. 
1.3.1 Food 
The use of seaweed directly as human food is very popular in Asia, particularly 
in Japan, China and Korea. Porphyra, Ulva, Alaria, Chlorella, Chondrua, 
Rhodymenia and Nostoc are the commonly used algae. The most important algae is the 
red algae Porphyra, which is known as "nori" in Japan, "zicai" in China, and “purple 
laver” in Great Britain (Lembi and Waaland, 1988). These edible seaweeds are eaten 
as a vegetable or used to prepare soup, salad, pickles, etc. Seaweeds are known as a 
good diet food because they are "filling" and can regulate bowel action without 
damaging intestinal walls (Guiry and Blunden, 1991). They contain significant 
amounts of protein, vitamins and minerals essential for human nutrition (Lobban and 
Wynne, 1987) and seaweed products are even made into tablets and sold as a mineral-
vitamin supplement in health food stores. 
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1.3.2 Industrial uses 
Phycocolloids extracted from seaweeds are important in food, pharmaceutical, 
textile，paint, paper, plastic, cosmetic, and other industries. They include agar and 
carrageenans from red algae, and alginates from brown algae (Dring, 1992). About 
108,229t, 81，858t and 826，178t (dry weight) of agar, carrageenans and alginates, 
respectively are produced in 1994/1995 (Zemke-White and Ohno, 1999). 
Agar is used in food processing for making bakery products, candies and wines 
as well as in industrial applications for adhesives, cosmetics, toolmaking and 
electrophoretic gels. Agar has some medical applications including use as dental casts, 
bulk laxative and formative structure in pills and capsules. It is also used for culture 
media in microbiological research (Clayton and King, 1990; Dawes, 1998). 
Carrageenan is used as stabilizer or gelling agent in milk-based products to 
make them smooth and creamy (Abbott, 1996). It is also utilized in the cosmetics， 
coating such as paints and inks, and brewing industries. Carrageenan is employed as a 
remedy for cough and as a pharmaceutical emulsifier. 
Alginate comprises the largest amount used in industrial applications among 
the phycocolloids. Alginates are primarily utilized in the paper and textile industries 
(50%). It is used to improve ink holdout and smoothness of the paper in the paper 
industry. In textile industry, fiber-reactive dye pastes are thickened with alginates to 
print sharp lines and conserve dyes (Lembi and Waaland, 1990; Dawes, 1998). It is 
used in food industry (30%) for making frozen desserts, salad dressings, bakery 
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products and beverages. It is also used in cosmetic and pharmaceuticals industries and 
in dental impression materials (Lembi and Waaland, 1990; Dawes, 1998). 
1.3.3 Agricultural Uses 
1.3.3.1 Fertilizer 
Seaweed has long been utilized as an agricultural fertilizer. Many species of 
seaweeds are made into organic and liquid fertilizer. The former is usually richer in 
potassium but is poorer in nitrogen and phosphorus than the farm manure. Liquid 
fertilizer (a concentrated extract of seaweed), e.g. "Maxicrop" and "Algafer" are 
mostly used in agriculture (Dawes, 1998). The advantages of seaweeds as fertilizer are 
because they are cheap and contain high content of trace elements. Seaweeds also 
contain growth regulatory substances, such as auxin, cytokinin, and may inhibit 
certain pathogens, including virus-carrying aphids and some fungi (Chapman, 1970; 
Lobban and Wynne, 1981; Lembi and Waaland, 1990). In addition, seaweed may act 
as soil modifier by improving the texture of soil (Dawes, 1998). 
1.3.3.2 Fodder 
The brown algae such as Ascophyllum and Laminaria are used as fodder for 
sheep, cattle and horses (Chapman, 1970). This is due to the high vitamin and mineral 
content of the seaweed meal. At present, there are some commercial mixes or seaweed 
additive available for animal feeds. Jensen (1958) demonstrated that the ewes 
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receiving seaweed (A. nodusum) meal (35g daily) had a greater wool production and a 
tendency to improve fertility. The cows receiving 200g mineral-enhanced A. nodosum 
meal (78.4% A. nodusum meal + 20% CazPzO? + 1.2% MgO + 0.06% CUSO4) 
everyday had better fertility and produced a milk yield 6.8% above that of the control 
group. The increased content of iodine in the milk was also observed after 1 nodosum 
meal (Guiry and Blunden, 1991). 
1.3.4 Medicinal properties 
Seaweeds have been used as medical purposes for centuries. They may be used 
for treatment of goitre，an iodine deficiency disease of the thyroid gland. Brown algae 
(e.g. Fucus) which contain iodine is effective for curing goitre (Chapman, 1970， 
Lobban and Wynne, 1981). Japan has a low incidence of goitre due to the fact that 
they consume large amount of algae. Alga was also effective in the treatment of 
vermifuge for expelling ascarids (Zeng and Zhang, 1984). Alsidium sp., Corallina sp” 
and Digenea sp. were shown to consist of kainic and a-allokainic acids which are 
effective as a vermifuge. Alga has also been used as antipyretics, cough remedies, and 
treatment of hypertension, urinary disease, constipation, asthma and other disorders 
(Zeng and Zhang, 1984). 
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1.4 Pharmacological effects of marine macroalgae 
Marine algae have been used since ancient time as medical purposes in the 
treatment of cancer, heart disease and other health problems. It is known that the 
products extracted from the algae are novel substances such as polysaccharides and 
phenolic compounds with well recognized pharmacological and biological activities to 
human life in therapeutic applications (Reiner et aL, 1962; Lobban and Wyune, 1981; 
Harada etaL, 1997; Hudson et al, 1999). 
1.4.1 Antioxidative activity 
Antioxidant activity has been reported recently from a number of marine algal 
extracts (Cahyana et al., 1992; Lee et aL, 1996; Matsukawa et aL, 1997; Yan et aL, 
1999). A methanolic extract of Ecklonia stolonifera, a brown alga, exhibited a radical 
scavenging effect on l,l-diphenyl-2-picrylhdrazyl (DPPH) radical in mouse liver 
homogenate (Lee et al., 1996). Phlorotannins isolated from S. kjellmanianum shows 
antioxidant activity, which has potential for preventing fish oil rancidity (Yan et al.’ 
1996). 
1.4.2 Hypotensive activity 
It is known that laminine isolated from the brown algae of the Laminariaceae 
family is capable of lowering blood pressure (Girard et aL, 1988; Ito and Hori, 1989). 
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Laminine has a hypotensive effect on male Wistar rat as a result of ganglion-blocking 
effect (Girard et al., 1988). Chiu and Fung (1997) found that the extract of Laminaria 
japonica could dose-dependently decrease blood pressure in the normotensive rat 
through intravenous injection. Rats fed with Laminaria ochotensis, Gloiopeitis renax, 
and Porphyra yezoensis powder for 28 days showed a remarkable decrease in systolic 
blood pressure to 88，89 and 90% of the control group, respectively (Ren et al., 1994). 
1.4.3 Antiviral activity 
Sulfated polysaccharides isolated from marine algae has been shown to possess 
antiviral effects (Carlucci et al., 1997; Hudson et al., 1999). Carlucci and others (1997) 
investigated the sulfated galactan from Cryptopleura ramosa, a red seaweed, against 
strains of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) by a plaque 
reduction assay in Vero cells, showing that the compound could protect Vero cells 
against both viruses, only if it was present at the time of inoculation. However, if 
added after cell adsorption the compound was no longer effective. A sulfated 
polysaccharide from Nothogenia fastigiata exhibited a selective inhibitory activity 
against several strains of HSV-1 and HSV-2 replication in vitro (Kolender et al., 1997). 
1.4.4 Antimicrobial activity 
A number of chemical components isolated from marine algae, such as fatty 
acids，terpenes, halogenated aliphatic compounds, bromophenols and phlorotannins 
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are responsible for their antibacterial activity, (Sieburth and Conover, 1965; Espeche 
e/ al, 1984; Rosell and Srivastava, 1987; Sastry and Rao, 1995). Bromophenols and 
phlorotannins are found in many species of the Rhodophyta and Phaeophyta, 
respectively (Ito and Hori, 1989). Rosell and Srivastava (1987) demonstrated that fatty 
acids of brown algae inhibited the growth of bacteria (e.g. M luteus, B. subtilis, S. 
aureus. Ps. fluorescens, B. cercus, Br. Catarrhalis, P. vulgaris, E. coli, and S. 
marcescens) using the disc-diffusion method. The different fractions isolated by 
HPLC from Spyridia filamentosa, a red alga, were shown active against five 
pathogenic bacteria indicating multiple antibiotic properties were present in the algae 
(Tovar and Ballantine, 2000). 
1.4.5 Antitumor activity 
Several studies reported that marine algae had antitumor activity (Maruyama 
and Yamamoto, 1984; Yamamoto et al., 1984; Harada et a!., 1997). In in vitro studies, 
both aqueous and methanol extracts of some marine algae from Japan's coasts were 
found to exhibit antitumor activity against mouse lymphocytic leukemia L1210 
(Harada et al, 1997). Cladophorapsis vaucheriaeformis in particular, showed strong 
activity against L1210 tumor cells with low cytotoxicity to normal NIH-3T3 cells 
(Harada er^?/., 1997). 
In in vivo studies, fucoidan fraction from Laminaria religrosa increased the 
life span of L1210-bearing mice (treatment group) to 33% or more compared to the 
mice (control group) (Maruyama and Yamamoto, 1984). Mayer and Panick (1984) 
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demonstrated that Macrocystis pyrifera exhibited significant antitumor activity against 
both P-388 lymphocytic leukemia and Ehrlish ascites. Nine out of 12 Ehlich ascites-
bearing mice of the treatment group could survive for nearly 90 days, whereas the 
mice of control group could only survive 23 ± 3 days. 
1.4.6 Hypocholesterolemic activity 
Seaweed has been shown to have antihyperlipidermic activity. Ren and others 
(1994) reported that seaweeds {Laminaria diabolica, Sargassum ringgoldianum, 
Padina arborescens, Porphyra yezensis and Gelidium amansii) could enhance the 
serum high density lipoprotein (HDL) level in hypercholesterolemic rat, which might 
protect against the development of atherosclerosis. Some of the seaweed could 
significantly lower the level of serum total cholesterol and also reduced the 
Atherogenic Index of serum as compared with that of the control group (Ren et al, 
1994). The sterols of marine algae, Fucus gardheri and Sargassum muticum were 
demonstrated to lower 83% and 59%, respectively of the blood cholesterol level in 
chick fed with diet containing algal sterol for 14 days (Reiner et al., 1962). 
1.5 Objectives 
A number of marine algae from different areas (e.g. Europe, Asia) have been 
tested for their biological and pharmacological activities. However, there are little 
information available for biologically active compounds isolated from marine algae 
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from Hong Kong. One aspect of this study was to screen the aqueous and methanol 
extracts of certain selected marine algae for their antioxidative activities. Three 
different antioxidative assays were used, namely superoxide radical scavenging 
activity using phenazin methosulfate-NADH-nitroblue tetrazolium system, inhibition 
of hemolysis of rat RBC initiated by AAPH, and suppression of Fe^Vascorbate 
induced lipid peroxidation. The phenolic compounds from the methanolic extract of 
Sargassum siliquastrum was further isolated and identified, since it produced the 
strongest antioxidant activity among the seaweeds tested. Furthermore, an attempt was 
made to correlate the phenolic content of the fractions isolated with the antioxidant 
activities. 
It has been reported there was an increase in free radicals in patient with 
uncontrolled essential hypertension (Kumar and Das, 1993). Therefore, the second 
objective of the present study was to investigate the hypotensive effects of the aqueous 
and methanol extracts of the marine algae in anaesthetized normotensive rat. The 
mechanisms of the hypotensive actions of these extracts were studied by using 




FREE RADICAL SCAVENGING AND 
ANTIOXIDATIVE ACTIVITIES OF MARINE MACROALGAE 
2.1 INTRODUCTION 
2.1.1 Free radicals: definition and sources 
A free radical is defined as 'any chemical species that has one or more 
unpaired electrons' (Rice-Evans, 1991; Frei, 1994). Many free radicals are unstable 
and highly reactive. Oxygen is essential for animals and human life; without it, we 
cannot survive. Yet, oxygen can be toxic to living tissues, because highly reactive 
oxygen-derived radicals, for example superoxide anion, O2'"; hydroxyl radical, OH'; 
and hydrogen peroxide, H2O2, are formed by exogenous chemicals or endogenous 
metabolic processes. The chemical reactivity of free radicals can damage all types of 
cellular macromolecules, including proteins, carbohydrates, lipids, and nucleic acids, 
resulting in cell death and tissue damage. 
2.1.2 Free radical-induced damage: 
2.1.2.1 Biological lipid peroxidation 
Oxygen free radicals are very toxic to cells because they can readily combine 
with other molecules, such as enzymes, receptors, and ion pumps, causing oxidation 
directly, and inactivating or inhibiting their normal function (Frei, 1994). They can 
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also interfere with nucleic acid function, generating alterations in the base sequence 
with the potential for mutations, leading to cancer. 
In biological system, one of the most destructive effects is the initiation of lipid 
peroxidation by autoxidation which occurs mainly in biomembranes, where the 
content of unsaturated fatty acids are relatively high, leading to destruction of the 
cellular membrane (Madhavi et al, 1996). Autoxidation is known to proceed by a 
radical chain reaction. A reaction starts when a radical abstracts a hydrogen from 
polyunsaturated fatty acid (PUFA) in the cell membrane. A radical chain reaction can 
be distinguished in three distinct steps: initiation, propagation and termination. 
Initiation: LH (Lipid) — H ' + L ' (lipid radical) 
Propagation: L* + O2 — LOO* (lipid peroxyl radical) 
LOO. + LH ^ L ' + LOOH (lipid hydroperoxide) 
Termination: L* + L* ) 
L* + LOO* non radical products 
� 
LOO* + LOO' 
The oxidation products, hydroperoxides may decompose to produce 
malondialdehyde (MDA) or other aldehydes, ketones, ethers, alcohols, and 
hydrocarbons. They can contribute to the toxic effects exerted in hydrophobic domains 
which cause cellular damage and is related to aging and diseases, such as 
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atherosclerosis, diabetes, cancer, and ischemia-reperfusion injury (Frei, 1994). The 
determination of MDA is a common assay for lipid peroxidation. In the present study, 
the measurement of MDA will be used in the lipid peroxidation assay (2.2.4). 
2.1.2.2 Lipid oxidation of foods 
Lipids are present in almost all foodstuffs, and most of them are in the form of 
triglycerides, which are esters of fatty acids and glycerol. They are very susceptible to 
lipid oxidation. Lipid oxidation occurs at the unsaturated sites of the fatty acids. The 
more polyunsaturation in a food, the more likely is peroxidation occur. Lipid oxidation 
can lead to the development of rancidity and off-flavors, which result from the 
formation of aldehydes and ketones. This rancidity of the fat is potentially toxic by 
products. The oxidation can also cause discoloration of pigments, loss of product 
flavor and odor, changes in texture, reduction in shelf-life and nutritional value due to 
loss of vitamin activity (Lea, 1962; Madhavi et a/., 1996). 
The oxidation of polyunsaturated lipids in food can be initiated by enzymatic 
and non-enzymatic mechanisms. The oxidation is often caused by free-radical 
reactions, which can be catalyzed by many environmental factors, e.g. heat, oxygen, 
light, ionization reactions, trace metals and metalloproteins (Madhavi et al, 1996). 
Hydroperoxide can also be formed from the reaction catalyzed by the enzyme 
lipoxygenase. Lipoxygenases have been implicated in the oxidation damage to foods 
observed during storage conditions. Chicken and fish possess lipoxygenase activities, 
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which play a role in the rancidity development in the stored chickens and during post-
harvest bleaching of carotenoids of fish skin (Hsich, 1994). 
2.1.3 Antioxidants 
2.1.3.1 Antioxidants 
The human body has evolved many types of antioxidant defenses to protect 
against reactive oxygen species generated, but these defenses are not completely 
efficient. Therefore, there is ongoing oxidative damage to DNA, lipids, and proteins in 
the human body. An antioxidant is defined as "a substance that, when present at low 
concentrations compared with those of an oxidizable substrate, significantly delays or 
prevents oxidation of that substrate" (Halliwell, 1995). Alternatively, according to the 
US Food and Drug Administration (FDA), antioxidants are defined as substances used 
to preserve food by retarding deterioration, rancidity or discoloration due to oxidation. 
There are literally hundreds of naturally occurring antioxidants. Some 
antioxidants are produced by the body, while others must be obtained from food or 
supplements. 
One important line of defense in human body is a system of enzymes, 
including superoxide dismutase，catalase and glutathione peroxidase, which decrease 
the concentration of the most harmful oxidants (Davies, 1995; Madhavi et al., 1996). 
A second line of defense is antioxidants that are found in the diet including 
vitamin E (tocopherol), vitamin C (ascorbic acid), carotenoids, and other natural and 
synthetic antioxidants or free radical scavengers (Madhavi et al, 1996). Most of the 
antioxidants found in the foods are phenolic or polyphenolic compounds. 
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2.1.3.2 Antioxidant Mechanisms 
A variety of antioxidants have evolved to interrupt free radical autoxidation, 
thus inhibiting initiation and propagation of the chain reaction. Antioxidants can act at 
different levels in the oxidative sequence as follows (Frankel, 1995; Madhavi et al., 
1996): 
1. Preventing chain initiation by scavenging initiating radicals such as HO* 
and (V—； 
2. Binding metals ions in forms that will not generate initiating species such 
as HO•，ferryl, or Fe^V Fe^+ZO� and / or will not decompose lipid 
hydroperoxides to peroxyl and alkoxyl radicals; 
3. Decomposing or reducing hydroperoxides by converting hydroperoxides 
into stable hydroxy compounds (e.g alcohols) by reduction or hydrogen 
donation; 
4. As synergists, which reinforce the activity of multi-component antioxidant 
systems. Vitamin C and vitamin E are known to be highly effective in 
combination, where vitamin C reinforces the antioxidant effect of vitamin 
E by regenerating the active form of the vitamin after it has reacted with a 
free radical; and 
5. Chain-breaking, that is, by scavenging peroxyl and alkoxyl radicals to 
prevent continued hydrogen abstraction. Thus, the chain propagation of 
lipid peroxidation is stopped and the formation of hydroperoxides and 
aldehydes is inhibited. Tocopherol is a lipid-soluble molecule which acts as 
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a chain breaking antioxidant. It can scavenge lipid peroxyl radicals much 
faster than these radicals can react with adjacent fatty acid side chains. 
The —OH group of the tocopherol gives up its hydrogen atom to the 
peroxyl radicals, converting it to a lipid peroxide, but generating the 
corresponding tocopheroxyl radical. Although the chain reaction has not 
yet terminated, the tocopheroxyl radicals tend to be less reactive in a 
biological matrix than the peroxyl radicals，and the process of peroxidation 
is slow down. There is an evidence of regenerating tocopherol from its 
radical by ascorbic acid, or reduced glutathione (GSH) in vitro (Frei, 1994). 
2.1.4 Synthetic antioxidants 
Synthetic antioxidants have been used for a long time, most of them are of the 
phenolic type, with one or more hindered phenolic OH groups. Several synthetic 
antioxidants are commercially available and currently used / added to processed foods 
to prevent the peroxidation of lipids and thus flavor degradation during storage. They 
are butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), butylated 
hydroxyquinone (TBHQ) and propyl gallate (PG) (Figure 2.1). The differences in their 
antioxidant activities are due to their chemical structures which modulate the radical 
scavenger activity of the OH group，but also influence their physical properties such as 
volatility, solubility, and thermal stability (Madhavi et aL, 1996). The antioxidant 
mechanism of the synthetic phenolics involves the formation of a resonance-stabilized 










T e r t - b u t y l h y d r o q u i n o n e 
(TBHQ) Propyl qa\\a\e 
Figure 2.1 Structure of some synthetic antioxidants 
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reacts with oxygen to form antioxidant peroxides that can be autoxidized (Decker, 
1998). 
Among these, BHA and BHT are most widely used as antioxidants in food 
lipids. They are classified as "Generally Recognized as Safe" (GRAS) by the U.S. 
FDA. BHA and BHT are added to breakfast cereals, packaging, chewing gum, 
convenience foods, vegetable oils, processed meat and fish products, shortening, 
potato flakes, enriched rice, candy, and many other oil containing products. GRAS 
regulations limit their used to 0.02 percent, based on the fat content of the food (Jones, 
1992). However, in certain rancidity- prone but low-fat foods (e.g. dry breakfast 
cereals, instant potatoes), BHA and BHT at up to 50 ppm (0.005%) of the food itself is 
permissible as a regulated food additive (Jones, 1992). BHA and BHT are usually used 
in combination since they display synergism. 
Safety evaluation of synthetic antioxidants is an important consideration, 
because of the chemical changes during food processing and storage. The chemical 
changes of the antioxidants will react with the food components during processing, so 
the exposure to humans of these anthropogenic compounds of unknown biological 
activity is inevitable. Several studies reported on the effects of BHA on conversion of 
ingested material into toxic substances due to increased secretions of microsomal 
enzymes of liver and extra- hepatic organs, such as lungs and gastrointestinal tract 
mucosa (Watternberg, 1986; Hudson, 1990). 
In toxicology / carcinogenic studies, Brown et al (1959) and Wilder (1960) 
found that no toxic effects of BHA, administered to rats for 22 months and to dogs for 
15 months, respectively. However, from other researchers, BHA and BHT have been 
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reported to be carcinogenic. Administration of 2% BHA induced the increase in the 
incidence of squamous-cell carcinoma and papillomas of the male F344 rats 
forestomach (Ito et al., 1986). BHA also induced pronounced hyperplasia and 
papillomas in the forestomach of Syrian golden hamsters (Ito et al., 1986). The 
relevance of these results to humans is questionable because humans lack a 
forestomach. 01 sen Qt al, (1986) also reported that a dose-related increases in BHA 
induced benign and malignant hepatocellular neoplasms in Wistar rats of both sexes. 
BHA and BHT were promoters of urinary bladder neoplasia in male Fisher 344 rats, 
which was initiated with 0.01% or 0.05% of N-butyl-N-(4-hydroxybutyl)nitrosamine 
(BBN) by drinking-water (Ito et al., 1986). 
BHT has been reported to cause extensive hemorrhages in rats due to a 
disruption of the blood coagulation mechanism (Takashashi and Hiraga, 1978; 
Takashahi, 1992). Takashahi (1992) reported that administration of BHT at 0.5, 1.0 
and 2.0% to mice, resulted in massive hemorrhages in the lungs and blood pooling in 
various organs. BHA and BHT may alter the liver function and cause liver 
hypertrophy in rats. The effects of BHT are more pronounced than those of BHA. 
BHT can result in marked liver hypertrophy and a marked proliferation of the smooth 
endoplasmic reticulum (Branen, 1974). 
2.1.5 Natural antioxidants 
Since consumers are concerned about the safety and toxicity of synthetic 
antioxidants, this leads to decreased use of these antioxidants, although they have 
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marked antioxidant activities. Therefore, the development of alternative antioxidants 
from natural origins which are important for our health and in food industry have 
drawn more and more attention. 
Natural antioxidants are primarily plant polyphenolic compounds that may 
occur in all parts of the plant. They can be found in fruit, vegetables, nuts, seeds, 
leaves, flours, roots, and barks (Hudson, 1990). Many investigators have found 
different types of antioxidants in various kinds of plants (Larson, 1988). 
Naturally-occurring antioxidative components can be phenolic compounds 
(tocopherols, flavonoids and phenolic acid), nitrogen compounds (alkaloids, 
chlorophyll derivatives, amino acids and amines), or carotenoids as well as ascorbic 
acid (Larson, 1988; Hudson, 1990). 
Of the many natural antioxidants, tocopherols (vitamin E) are the most widely 
distributed and most extensively tested for antioxidant activity. Tocopherols occur 
naturally in plant tissues mostly in nuts, seeds, fruits and vegetables. They exhibit both 
antioxidant and vitamin E activities. They are important biological antioxidants which 
are an extremely effective chain-breaking antioxidant that protects polyunsaturated 
fatty acids and lipid components of cells and organelle membranes from free radical 
damage (Gutteridge and Halliwell，1994). They appear to be essential for the 
enhancement of immune response as well as prevention of several cancers, 
cardiovascular diseases, cataract, and Parkinson's disease (Madhavi et al., 1996). 
Tocopherols are demonstrated to be effective in a number of food products including 
meat, bakery, fats and oil. However, they are not very stable, which may be 
decomposed during processing and storage. 
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Vitamin C, which can be found in fresh fruits and vegetables is an effective 
free radical scavenger primarily related to its strong reducing potential. There is an 
evidence that vitamin C (reduced) plays an antioxidant role in the nervous system. 
Epidemiological study has found that a high dietary intake and high plasma 
concentration of vitamin C in elderly people correlated with a low risk of death from 
stroke (Gale et al., 1995). Vitamin C alone has minimal antioxidant activity, however, 
when used in combination with other antioxidants (e.g. vitamin E), it functions as a 
synergist by promoting their antioxidant effects (Frei, 1994). Vitamin C is widely used 
as a food additive, primarily because of its antioxidants and nutritional properties. 
Two naturally occurring antioxidants, P-carotene and flavonoids in the diet 
have been reported to reduce the risk of cancer and cardiovascular disease (Peto, 1981; 
Madhavi et al, 1996; Knekt, 1997; Heinonen et al, 1998b). They are major sources of 
red, yellow and orange pigment in fruits and vegetables. Carotenoids protect cells 
form oxidative stress by quenching triplet-state sensitizers and singlet oxygen, and by 
scavenging peroxyl radicals (Frei, 1994). Flavonoids exert their antioxidant activities 
by scavenging the lipid peroxidation-initiating radicals and chelating metals (Frei, 
1994). 
In addition to fruits and vegetables, spices and herbs are also good sources of 
antioxidants. Among herbs, rosemary is often shown to exhibit the most potent 
antioxidant activity and commercially significance. Rosmariquinone and 
rosmaridighenol were identified by Houlihan et al (1984 and 1985) as antioxidant 
constituents of rosemary with potency equal or superior to that of BHA and BHT in 
2 6 
lard. Barbut et al (1985) reported that addition of rosemary extract to the meat was 
able to increase protection from oxidation during cooking. 
A number of natural antioxidants have been developed to inhibit lipid 
peroxidation, some of which, for example, vitamin E, vitamin C and rosemary extract, 
are extensively used. However, they are of limited value because they are not as 
effective as the synthetic antioxidants (Sherwin, 1990; Loliger, 1991). Tocopherols do 
not always provide effective protection against in vitro oxidation. Tocopherols are 
usually less stable and will be degraded during heat processing (Madhavi et al” 1996). 
Although rosemary extracts have excellent antioxidative properties, their color, odour 
and taste limited their usefulness (Loliger, 1991). Therefore, research on other new 
and effective as well as safe natural antioxidants has gained much momentum. 
2.1.6 Objectives 
Marine algae are considered as a rich source of antioxidants (Fujimoto and 
Kaneda, 1984; Cahyana et al., 1992; Lee et al, 1996; Matsukawa et al., 1997). They 
contain bioactive compounds with biopharmaceutical potential (Konig et al., 1994). 
However, marine algae from the Hong Kong waters have not yet been thoroughly 
investigated. Therefore, the aim of the present study was to screen marine macroalgae 
which are abundant in Hong Kong for their antioxidative activities. Antioxidant 
activity was determined on the basis of the superoxide radical scavenging activity of 
the extracts using phenazin methosulfate-NADH-nitroblue tetrazolium system. 
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Antioxidant capability was also assayed by determining the inhibition of erythrocytes 
(RBC) hemolysis and suppression of lipid peroxidation using rat brain homogenates. 
2 . 2 METHODS AND MATERIALS 
2. 2. 1 Preparation of Algae Extracts 
Thirteen species of marine macroalgae (Table 2.1) were collected from 2 sites, 
Lung Lok Shui and A Ma Wan, Tung Ping Chau, which is located in the northeast of 
Hong Kong. Sampling was conducted during a period from December 1997 to Jun 
1998 (Figure 2.2). The algae were identified by Prof. Put Ang, Department of Biology, 
The Chinese University of Hong Kong. 
The algae were cleaned of substantial epiphytes growth, silt and sand by 
carefully rinsing in fresh water. 
Each fresh alga was weighed and mixed with 3 volumes of cold distilled water 
and homogenized for 4 min with a Waring blender. The homogenate was left standing 
overnight at 4 � C and then centrifuged at 23,700g (Beckman J2-M1) at 4°C for 20 mins. 
The supernatant was separated and lyophilized. The dry powder obtained was 
designated as the aqueous extracts used in the subsequent studies (Figure 2.3). 
The residue material after centrifugation was also freeze-dried. The dry residue 
(lOg) was then re-extracted in a Soxhlet apparatus for 6 hr with methanol (300ml) 
twice. The solvent extract solution was concentrated in a rotary evaporator under 
vacuum at 40°C. The dried extract so obtained was a dark green semisolid and 
designated as methanol extract. The methanol extract was stored at 4°C under nitrogen. 
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Table 2.1 Marine macroalgae collected from Tung Ping Chau in Hong Kong from 
December 1997 to Jim 1998 
Phylum Species Site of collection 
Brown algae 1. Colpomenia sp. A Ma Wan 
2. Endarachne binghamiae A Ma Wan 
3. Myograpsis sp. Lung Luk Shui 
4. Lobophora vahegata Lung Luk Shui 
5. Pachydictyon coriaceum Lung Luk Shui 
6. Padina arborescence A Ma Wan 
7. Padina australis A Ma Wan 
8. Punctaria sp. Lung Luk Shui 
9. Sargassum angustifolium Lung Luk Shui 
10. Sargassum siliquastrum Lung Luk Shui 
Green algae 11. Enteromorpha sp. A Ma Wan 
Red algae 12. Galaxaura sp. Lung Luk Shui 
13. Hypnea chawides A Ma Wan 
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Sargassum siliquastrum 
Hypnea charoides Enteromorpha sp. 
Figure 2.2 Some of the seaweeds used in this study, S. siliquastrum, Hypnea 
charoides, and Enteromorpha sp. 
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Figure 2.3 Preparation of aqueous and methanol extracts from marine algae. 
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2.2.2 Determination of Free Radical Scavenging Activities 
2.2.2.1 Superoxide anions scavenging activity (Liu et al” 1997) 
Superoxide anions were generated in a non-enzymatic system. Superoxide 
radical scavenging activity assay was generated from the phenazin methosulfate-
NADH-nitroblue tetrazolium system. The influence of extracts on generation of 
superoxide was evaluated by spectrophotometric measurement of the product on 
reduction of nitroblue tetrazolium (NBT). The reaction medium contains 16mM Tris-
HCl buffer (pH 8.0), 78|uM (3- nicotinamide adenine dinucleotide (reduced form, 
NADH)，50^M NBT, 10 ^iM phenazin methosulfate (PMS) and seaweed extracts with 
different concentrations. The blank sample contained no NADH. The color reaction 
was measured at the absorbance at 560nm by spectrophotometer (Milton Roy 
Spectronic 3000)，against the blank sample. Vitamin C and glucose were used as a 
positive and negative control，respectively in this experiment. All tests were run in 
three replicates. The superoxide radical scavenging activity was calculated by the 
following equation: 
% inhibition of superoxide radical = (A - Ai)/A x 100 
where A was the absorbance of control group, and A 丨 was the absorbance of 
test sample groups. 
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2.2.3 Antioxidative activity using hemolysis assay (Mild et al” 1987) 
2.2.3.1 Preparation of Red Blood Cells (RBC) 
Male Sprague-Dawley rats (200g) were used in this experiment. Blood 
obtained from the posterior vena cava was collected into a heparinized tube. The 
erythrocytes red blood cells (RBC) were centrifuged and washed three times with 
phosphate-buffered saline (PBS), and the plasma and buffy coat were carefully 
removed by aspiration after each wash. During the last washing, RBC were 
centrifuged at lOOOg, for 10 min to obtain a constantly packed cell preparation. 
Washed RBC were finally resuspended in the buffered saline [125mM NaCl and 
lOmM sodium phosphate buffer (pH 7.4)] or PBS to obtain a 20% RBC suspension. 
2.2.3.2 Hemolysis Assay 
Hemolysis of RBC mediated by 2, 2 ' - azo- bis (2- amidinopropane) 
dihydrochloride (AAPH, a peroxyl radicals initiator) was measured according to the 
method of Miki et al (1987). A portion of RBC suspension (0.1ml) was mixed with 
0.1ml PBS solution containing different concentrations of seaweed extracts. An 
aliquot of 200mM AAPH (0.2ml, in PBS) was then added to the mixture. The reaction 
mixture was shaken and incubated in a water bath at 37°C for 3 hours. After 
incubation, one of the reaction mixtures was diluted with 8ml of PBS (A), and the 
other was diluted with 8ml of distilled water (B) to induce hemolysis. Both reactions 
were centrifuged at lOOOg for lOmin. The absorbance of both supernatants at 540nm 
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was recorded by a spectrophotometer. Vitamin C was used as a control in this 
experiment. The percent inhibition was calculated by the following equation: 
% inhibition = (1 - A/B) x 100 
2.2.4 Lipid Peroxidation Assay 
2.2.4.1 Preparation of rat brain homogenates (Sewerynek et al” 1995) 
Male Sprague-Dawley rats with weight of 150g were used. Rat brain was 
removed quickly and washed with ice-cold 20mM Tris-HCl buffer (pH 7.4). The brain 
was homogenized in 2 volumes of ice-cold Tris-HCl buffer using a Polytron PT 3000 
Homogenizer, followed by centrifugation at 3000g for lOmin. The supernatant 
fraction was used for the study of lipid peroxidation. 
2.2.4.2 Measurement of Lipid Peroxidation 
Lipid peroxidation was assayed using the formation of malodialdehyde (MDA) 
as an indicator. The effect of seaweed extracts on brain homogenate induced by 
FeS04-Ascorbic acid stimulated lipid peroxidation was determined by the method of 
Liu et al, (1997). The reaction mixture composed of 0.1ml of brain homogenate, 0.1ml 
of 10|iM FeS04，0.1ml of 0.1 mM ascorbic acid and 0.2ml of seaweed extract with 
different concentrations. The mixture was incubated at 37°C for 1 hour. The reaction 
was stopped by adding 0.5ml of 28% trichloroacetic acid (TCA) and 0.38ml of 2% 
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thiobarbituric acid (TBA). The mixture was than heated at 80% for 20min. After 
cooling, centrifugation was carried out for lOmin. The absorbance of MDA-TBA 
complex in the supernatant was determined at 532nm by a spectrophotometer. 
Butylated hydroxyanisole (BHA) was used as the control in this experiment. The 
percent inhibition was calculated by the following equation: 
o/o inhibition = (1 - A/B) x 100 
where A was the absorbance of the test sample groups, and B was the 
absorbance of the control group (without sample). 
2.2.5 Statistics 
All values are expressed in Mean 士 SEM. Student's /-test was used wherever 
applicable. The level of significance was set at ；7<0.05. 
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2.3 RESULTS 
The yields of the aqueous and methanol extracts from 13 marine algal species 
are shown in Table 2.2 and Table 2.3 respectively. Freeze-dried powder of aqueous 
extracts from different species had different colours. The colour of methanol extracts 
of all species was a dark green semisolid. The yield of aqueous and methanol extracts 
could not be compared because the yield of aqueous extract was calculated from the 
wet weight of marine algae, and methanol extracts was calculated from the dry weight 
of the algal water-insoluble residue. 
2.3.1 Superoxide radical scavenging activity of algal extracts 
The ability of the aqueous and methanol extracts of marine algae to scavenge 
superoxide generated by phenazin-methosulfate-NADH is shown in Table 2.4 and 
Table 2.5, respectively. Most of the aqueous extracts had a strong scavenging action 
on superoxide radicals, except Colpomenia sp. and E. binghamiae. The strongest 
scavenging effect being exhibited by Myograpsis sp., S. siliquastrum and H. charoides, 
as they were able to suppress superoxide generated by more than 50% at a 
concentration of20|Lig/ml (Table 2.4). However, all of the methanol extracts of marine 
algae exhibited relatively much lower scavenging effect on superoxide radicals as 
compared to aqueous extracts (Table 2.5). 
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Table 2.2 The yield and colour of powder of the aqueous extracts from 13 marine 
algae species after lyophilized. The percentage yield was calculated from fresh 
weight of algae. 
Phylum Species Yield (%) Colour of powder 
Brown algae 1. Colpomenia sp. 0.32 light brown 
2. Endarachne binghamiae 0.95 light brown 
3. Myograpsis sp. 1.29 light brown 
4. Lobophora variegata 0.53 brown 
5. Pachydictyon coriaceum 0.33 red brown 
6. Padina arborescence 0.60 dark brown 
7. Padina australis 0.40 dark brown 
8. Punctaria sp. 0.47 dark green 
9. Sargassum angustifolium 2.94 light brown 
10. Sargassum siliquastrum 1.21 dark brown 
Green algae W. Enteromorpha sp. 0.81 light green 
Red algae 12. Galaxaura sp. 1.11 red 
13. Hypnea charoides 0.28 pink 
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Table 2.3 The yield of the methanol extracts from 13 marine algae species. The 
percentage yield was calculated from dry weight of algal water-insoluble residue. 
Phylum Species Yield (%) 
Brown algae 1 • Colpomenia sp. 2.66 
2. Endarachne binghamiae 2.41 
. Myograpsis sp. 2.00 
4. Lobophora vahegata 3.60 
5. Pachydictyon coriaceum 10.1 
6. Padina arborescence 2.50 
7. Padina austral is 4.87 
8. Punctaria sp. 14.5 
9. Sargassum angustifolium 6.37 
10. Sargassum siliquastrum 7.64 
Green algae 11. Enteromorpha sp. 4.50 
Red algae 12. Galaxaura sp. 2.25 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.3.2 Effects of algae extracts on hemolysis assay 
Table 2.6 shows the antioxidative effects of aqueous extracts of marine algae 
on the hemolysis of rat RBC initiated by AAPH. Six brown algae species, L variegata, 
P. arborescence, P. australis, Punctaria sp., S. angustifoliun and S. siliquastrum 
exhibited strong inhibition (>80%) of RBC hemolysis. The inhibitory effects of P. 
arborescence and S. siliquasrtum were shown to be higher than that of vitamin C 
which acted as a control in this experiment. At a concentration of 50|Lig/ml, P. 
arborescence and S. siliquastrum inhibited hemolysis by 76.29% and 62.25% 
respectively, as compared to the vitamin C which only had 44.27% inhibition. All of 
the species showed a dose-dependent inhibition of RBC hemolysis, except 2 species, 
namely P. arborescence and Galaxaura sp. This also occurred in vitamin C，where the 
inhibition rate was higher at low dose than at higher dose. Aqueous extracts of red and 
green algae were relatively less effective in inhibition of RBC hemolysis than the 
brown ones under the same conditions (Table 2.6). 
Table 2.7 lists the percentage inhibition of hemolysis induced by AAPH on the 
methanol extracts of marine algae. All of the species did not show a concentration 
dependent manner in inhibition of RBC hemolysis except S. angustifolium. Methanol 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The comparison of the inhibition of RBC hemolysis by aqueous and methanol 
extracts of different algae species at 50|ag/ml is shown in Figure 2.4. In all cases 
except P. coriaceum, P. arborescence and Galaxaura sp., the methanol extract was 
more inhibitory than the aqueous extracts. Among the 13 species tested, S. 
siliquastrum showed the highest antioxidant activity. 
2.3.3 Effects of algal extracts on lipid peroxidation assay 
Both aqueous and methanol extracts were tested for their ability to inhibit non-
enzymatic lipid peroxidation in the rat brain homogenates stimulated by ferrous ion. 
The result of FeSCU -Ascorbic acid-induced lipid peroxidation of the aqueous extracts 
is shown in Table 2.8. The formation of MDA decreased with the increasing amounts 
of most of the algal species. It was found that lipid peroxidation was inhibited by the 
aqueous extracts of brown and red algae but not the green algae. S. siliquastrum 
showed the highest antioxidant activity which caused 98% inhibition at a 
concentration of 0.25mg/ml, although the activity was less than that of BHA. 
The inhibition of lipid peroxidation by methanol extract of different algal 
species is shown in Table 2.9. At high concentration (1.25mg/ml), all of the species 
exhibited more than 80% inhibition of lipid peroxidation. However, at 0.05mg/ml, 
only 4 brown algal species, E. binghamiae, L variegata, P. coriaceum and S. 
siliquastrum were shown to have over 80% inhibition of this reaction. Of the 13 
species, S. siliquastrum showed the highest antioxidant activity, which caused 98% 
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inhibition even at a concentration of 2|Lig/ml. Its potency was similar to the control 
antioxidant, BHA. 
Figure 2.5 shows the inhibition of lipid peroxidation at 1.25mg/ml by both 
extracts of different algae species. The methanol extracts seemed to exhibit higher 
antioxidant activity than the aqueous extracts in most of the algal species tested. 
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Figure 2.4 Inhibitory effects of aqueous and methanol extracts of 
a marine algae on RBC hemolysis assay. The concentration of 
each extract was 50|Lig/ml. Each value is the mean 士 S.E.M.(n = 
3). 1: Colpomenia sp.; 2: Endarachne binghamiae; 3: 
Myograpsis sp.; 4: Lobophora variegata; 5: Pachydicyton 
coriaceum ； 6: Padina arborescence; 7: Padina australis; 8: 
Punctaria sp.; 9: S. angustifolium; 10: S. siliquastrum; 11: 
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Algae species 
Figure 2.5 Inhibitory effects of aqueous and methanol extracts 
of marine algae on lipid peroxidation assay. The concentration 
of each extract was 1.25mg/ml. Each value is the mean 士 
S.E.M.(n = 3). 1; Colpomenia sp.; 2: Endarachne binghamiae ； 
3: Myograpsis sp.; 4: Lobophora variegata; 5: Pachydicyton 
coriaceum ； 6: Padina arborescence-, 7: Padina australis ； 8: 
Punctaria sp.; 9: S. angustifolium ； 10: S. siliquastrum; 11： 
Enteromorpha sp.; 12: Galaxaura sp.; 13: //. charoides. 
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2.4 DISCUSSION 
In the present study, a series of in vitro tests were used to investigate the marine 
algae for their superoxide radical scavenging activity, their protecting effects against 
RBC hemolysis and their ability to suppress lipid peroxidation in rat brain homogenate. 
The oxidation of RBC membrane serves as a good model to study the 
peroxidative damage to biological membranes. RBC are very susceptible to 
peroxidation due to their membrane which is rich in polyunsaturated fatty acids and is 
exposed to a higher oxygen tension than all other tissues. Besides, RBC contain 
hemoglobin that is capable of initiating lipid peroxidation in the blood cell membrane 
to inactivate vital red blood cell enzymes, disturb the cell deformability, leading to 
circulatory impairment, and cause hemolysis when in the presence of reactive oxygen 
species (Chiu et al, 1989). The oxidative hemolysis of RBC induced by various 
agents，such as hydrogen peroxide, dialuric acid, xanthine oxidase, and 2, 2 ' -azo-
bis(2-amidinopropane) dihydrochloride (AAPH), have been extensively used as a 
model for damage in cell membrane by peroxidation (Miki et aL, 1987). 
In this study, AAPH was used to determine the hemolysis of RBC. It has been 
known that AAPH is a peroxyl radicals initiator that generates free radicals by their 
thermal decomposition in the aqueous region which attacks the RBC membrane from 
the outside (Miki et al, 1987). 
The generated peroxyl radicals will attack the RBC membrane to induce the 
chain oxidation of lipids and protein, which may disturb the membrane organization 
and eventually leads to hemolysis (Yamamoto et al, 1985; Miki et al, 1987). In the 
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present study, it was found that two of the aqueous extracts and two of the methanol 
extracts of brown algae, could inhibit hemolysis more than 50% at a dose of 50|ag/ml 
(Table 2.6 and 2.7). This suggests that they might be effective to protect RBC 
membranes against AAPH radical. No protecting effects against RBC hemolysis was 
observed on the methanol extract of E. binghamiae, P. coriaceum, Punctaria sp., 
Enteromorpha sp., and Galaxaura sp. because they only had less than 15% inhibition 
rate. In some cases such as in the methanol extract of E. binghamiae, they even 
promoted hemolysis of RBC. 
The inhibitory effects of the aqueous extracts of P. arborescence and S 
siliquastrum were found to be significantly (P<0.05) higher than that of vitamin C at a 
dose of 50|ig/ml. For the methanol extract, only S. siliquastrum was shown to have 
significantly (P<0.05) higher inhibition percentage than the control at a dose of 
50|Lig/ml. This indicated that some algal extracts could be significantly more efficient 
as a peroxyl radical scavenger than vitamin C. 
As shown in Table 2.6 and Table 2.7, some of the extracts did not show a dose-
dependent inhibition of RBC hemolysis. This perhaps is due to some toxic substances, 
when presented at a high concentration in the aqueous and methanol extracts, that 
could destroy the RBC and caused hemolytic effect, since these were not purified 
extracts. Another reason is that they may exhibit prooxidant effect. As seen in vitamin 
C, it can exhibit a prooxidant effect when used at a concentration of 1.25mg/ml. 
Madhavi et al (1996) reported that many antioxidants like vitamin C and phenolic 
antioxidant, BHA, at high concentrations, suffer from the loss of antioxidant activity 
and become prooxidant due to its participation in the initiation process. 
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It has been reported that methanol is widely used as an effective solvent for 
extraction of antioxidants (Economou et aL, 1991). Yen et al (1996) demonstrated 
that methanol extracts of mulberry leaves showed the strongest antioxidant activity 
than that by other organic solvents. Matsukawa et al (1997) also demonstrated that 
antioxidant effects of marine algae were stronger in the ethanol extract than those in 
the aqueous extract. The same results were found in the present study. Our results 
clearly show that the methanol extract had higher antioxidant potency than the 
aqueous extract with the exception of P. coriaceum, P. arhorencence and Galaxaura 
sp. in the hemolysis assay. This may be due to the fact that the methanol extracts 
contained more hydrophobic antioxidants that might be easily integrated into cell 
membrane structure which contain polyunsaturated fatty acid. For example, a -
tocopherol (vitamin E) which is a fat-soluble chain breaking antioxidant can protect 
cell membrane against free radical attack (Miki et al, 1987). This reveals that 
different extraction method / solvent does affect the antioxidant activity of algal 
extract. 
Lipid peroxidation is a major cause of many pathological effects and food 
deterioration. It is strongly affected by transition metals that catalyze many of the 
reactions involved in this process. Iron is a particularly important catalyst of lipid 
peroxidation. This is because it is able to react with oxygen to form reactive species 
that can initiate the peroxidation reaction or react directly in the propagating step 
(Halliwell and Gutteridge, 1984). 
Brain homogenates provide an ideal model system to determine the effects of 
antioxidant agent on lipid peroxidation. This is because brain continuously generates 
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excessive free radicals from mitochondrial oxidative activity and catecholamine 
catabolism. It is also very sensitive to damage due to the high levels of unsaturated 
fatty acids (Sewerynek et al, 1995). 
The determination of malondiadehyde (MDA) formation is a widely used 
method for investigating lipid peroxidation. Fe^Vascorbate mixture was known to 
stimulate lipid peroxidation in rat liver microsomes and rat brain homogenate (Zhou 
and Zheng, 1991; Liu et al., 1997; Huang et al, 1998). In the present study, MDA 
formed in rat brain homogenate as measured by TBA method was chosen to 
investigate lipid peroxidation activity. The results demonstrated that all of the aqueous 
extracts at a dose of 6.25mg/ml inhibited Fe^Vascorbate induced lipid peroxidation in 
brain homogenate except that of E. binghamiae and Enteromorpha sp. (Table 2.8). 
However, in the methanol extract, all of the species exhibited more than 80% 
inhibitory effects at 1.25mg/ml (Table 2.9). All of the species was shown to have 
dose-dependent reduction on MDA formation. The results showed that both extracts 
could retard lipid peroxidation indicating the presence of antioxidant compounds in 
these extracts. 
For both aqueous and methanol extracts screened in lipid peroxidation assay, 
although they exerted an effective antioxidant activity, relatively higher concentrations 
(0.25-6.25mg/ml) were required as compared to the control, BHA, except the 
methanol extract of S. siliquastrum which showed the highest antioxidant activity 
among 13 species. The potency of S. siliquastrum was similar to the positive control, 
BHA. There was a rapid and concentration-dependent increase in the antioxidant 
activity of methanol extract of S. siliquastrum and BHA until a concentration of 
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2|^g/ml, after which antioxidant activity maintained at around 98% inhibition. No 
statistically significant difference (P>0.05) was found for the antioxidant activity from 
2|Lig/ml to 1.25mg/ml between methanol extract of S. siliquastrum and BHA, 
indicating that their activities were closely related to the amount added. According to 
these results, the methanol extract of S. siliquastrum and BHA can effectively inhibit 
the Fe^Vascorbate induced peroxidation even at a rather low dosage. BHA is known to 
exhibit an antioxidant activity by rapid donation of electrons to lipid peroxyl radicals 
to break the chain reaction of lipid peroxidation terminating the chain reaction 
(Hudson, 1990; Madhavi et al, 1996; Decker, 1998). However, it is not clear whether 
S. siliquastrum acts as an antioxidant with a similar mechanism of BHA. 
MDA is a major product of lipid peroxidation and is reported to be toxic to 
living cells. The reaction between MDA and TBA produces a pink pigment when 
heating in an acidic medium (Kikugawa et al., 1992). Both aqueous and methanol 
extracts of all algae did not interfere with the thiobarbituric acid test, because the color 
formation did not change if they were added after incubation with TBA. However, the 
aqueous extract of H. charoides when at the highest concentration (6.25mg/ml) 
changed the color to yellowish brown when incubated with TBA alone. Supposely, the 
pink pigment would be formed if the extract did not have antioxidant activity. It is 
likely that the aqueous extract of H. charoides itself interfered with the thiobarbituric 
acid reagents after incubation. 
Superoxide anion acts as either a reducing agent or an oxidizing agent, 
depending on the substrate oxidation potential, and it cannot initiate lipid peroxidation 
under normal circumstances (Frei, 1994; Gutteridge and Halliwell, 1994). 
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Nevertheless, its activity as an active oxygen species comes from its potential to form 
more reactive species such as hydroxyl radical and hydrogen peroxide that actively 
participate in the initiation of lipid peroxidation (Halliwell and Gutteridge, 1984). 
Kellogg and Fridovich (1975) reported that superoxide indirectly initiated lipid 
peroxidation as a result of superoxide and the emerging hydrogen peroxide acted as 
precursors of hydroxyl radicals. Enzymatic and non-enzymatic systems such as 
xanthine oxidase and phenazin methosulfate-NADH, respectively produce the 
superoxide radical as a normal product of the one-electron reduction of oxygen. The 
latter system was used in this study. The reduction o f N B T to blue formazan was used 
as a probe of superoxide generation in this chemical system. Addition of any 
compound into this system which are capable to react with superoxide should decrease 
the rate of reduction o f N B T . 
Flavonoids and other plant phenolics have been reported to have superoxide 
radical scavenging activity. Robak and Gryglewski (1988) showed that flavonoids e.g. 
quercetin, myricetin and rutin were scavengers of superoxide anions when superoxide 
anions were generated by a non-enzymatic PMS-NADH system. However, 
nonflavonoids antioxidant showed no activity in this system. Phenolic compounds 
were also effective in the scavenging of superoxide anions (Zhou and Zheng, 1991). 
The aqueous extracts of eleven algae samples could inhibit the rate of NBT 
reduction, indicating the extracts had superoxide scavenging ability. Myograpsi sp., S. 
siliquastrum and H. charoides extracts were more effective than the other extracts 
which had more than 50% inhibition at a concentration of 20 \xg/ml All aqueous 
extracts were better than vitamin C as superoxide free radical scavengers. This might 
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be explained by the fact that these extracts could react with superoxide via a one-
electron transfer mechanism or hydrogen abstraction mechanism. However, the 
scavenging activity was not observed in all of the methanol extracts except P. 
australis, Enteromorpha sp. and H. charoides extracts. Some methanol extracts such 
as L. variegata and Punctaria sp. could probably stimulate N B T reduction. 
Superoxide can be generated when PMS is reduced by NADH，and is reoxidized by 
oxygen. Hence, these methanol extracts may reduce PMS, and thus increased 
superoxide production. 
The screening results of different algae species showed large differences in 
free radical scavenging activity in each assay. When we compared the biological 
activity of the seaweed extracts for their ability to inhibit RBC hemolysis and lipid 
peroxidation, it was found that most of the methanol extracts of each alga could 
effectively inhibit Fe^^-induced lipid peroxidation, but they only moderately 
suppressed RBC hemolysis. This result indicates that the methanol extracts inhibit 
iron-stimulated lipid peroxidation by scavenging lipid peroxyl radicals or inhibition of 
lipid hydroperoxides. However, some aqueous extracts such as those from 
Colpomenia sp. and Punctaria sp. which could protect RBC against hemolysis, only 
moderately inhibited lipid peroxidation. This observation suggests that, they may act 
as a free-radical chain reaction interrupter by trapping the f ree radicals mediated by 
AAPH and so terminating the chain reaction. They may also act as a peroxyl radical 
scavenger. Therefore, there was no correlation between inhibition of RBC hemolysis 
and lipid peroxidation because these two assays might involve in slightly different 
mechanisms, in inhibiting peroxyl radicals and lipid hydroperoxides, respectively. 
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For the brown alga, S. siliquastrum, the ability of both methanol and aqueous 
extracts to inhibit RBC hemolysis ( - 8 8 % inhibition) stimulated by AAPH was similar 
to the antioxidant activity observed in lipid peroxidation assay (�98o/o inhibition) 
which was stimulated by Fe^'^/ascorbate mixture. Even though the mechanisms of both 
assays for antioxidant activity are slightly different, the two extracts ofS. siliquastrum 
still showed high antioxidant activity in both assays. Matsukawa et al (1997) 
demonstrated that both the aqueous and ethanol extracts of S. siliquastrum showed 
high radical scavenging activity. They also found that most of the Sargassum species 
have higher antioxidant activity than the other algal species. 
Superoxide and hydroxyl radicals are the most important source for initiating 
the lipid peroxidation. Superoxide cannot initiate the reaction under normal 
circumstances, but it can produce hydroxyl radical which is the most reactive oxygen 
radical (Frei, 1994). The extracts which have inhibitory action on lipid peroxidation 
are most likely to possess scavenging action towards superoxide anion, as seen in 
some extracts such as the aqueous extracts of Myograpsis sp. and S. siliquastrum, 
which exhibit strong scavenging of superoxide radical. On the other hand, some 
extracts such as the methanol extracts of P. coriaceum and Galaxaura sp., were not 
scavenger of superoxide anions and therefore their inhibitory action on the MDA 
formation might be related to the scavenging of hydroxyl radicals. 
In the present study, the antioxidant activity of green and red algal extracts 
were less effective than most of the brown algae extracts. Nevertheless, there were a 
few brown algal extracts which have either similar or less antioxidant activity than 
those of red and green algae. For instance, the methanol extract of Colpomenia sp. had 
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less antioxidant potency than both red and green algal extracts in inhibiting 
Fe^Vascorbate-induced lipid peroxidation. Yan et al. (1999) demonstrated that the 
brown seaweed had higher free radical scavenging activity than those in red and green 
seaweed evaluated by DPPH assay. Polyphenols are known to inhibit lipid 
peroxidation and possess powerful antioxidant properties (Haslam, 1989). This is due 
to their ability to inactivate or scavenge free radicals. It has been reported that seaweed 
contains large amount of polyphenols. For example, the antioxidant compound 
isolated from brown algae, Sargassum sp. was phlorotannins (Yan et cd； 1999), and 
that from red alga, Polyshiponia ulceolate was bromophenols (Lee et al” 1996) and 
from green algae, Enteromorpha sp. was chlorophyll a-related compounds (Cahyana 
et al., 1992). 
The present results showed that the aqueous and methanol extracts of some 
marine algae had appreciable superoxide radical scavenging activity and they were 
also able to suppress RBC hemolysis and inhibit Fe^Vascorbate induced lipid 
peroxidation. This suggested that they could effectively prevent biological 
peroxidation and protected cells against oxidative damage. The antioxidant activity of 
the methanol extracts was higher than that of the aqueous extracts, probably indicating 
that marine algae contained different active antioxidant compounds that existed in 
aqueous and methanol extracts. However, we still do not know how the components of 
these algae function as an antioxidant agent. Among the 13 marine algae species, S. 
siliquastrum exhibited the highest potency antioxidant activity against Fe^Vascorbate 
induced lipid peroxidation and RBC hemolysis. 
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Many diseases have been related to the induction of lipid peroxidation, e.g. 
rheumatoid arthritis, cancer, inflammation, hypertension, etc. Use of natural 
antioxidant for the treatment of disease is indeed safer than the synthetic one. Marine 
algae screened in the present study showed the potential to protect cells and prevent 
lipid peroxidation. They perhaps could be used in the development of new therapeutic 
drugs. Besides, they may also be useful in food industry to prevent oxidative spoilage 
of foods. 
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C H A P T E R 3 
ISOLATION OF ANTIOXIDATIVE PHENOLIC 
COMPOUNDS FROM SARGASSUM SILIQUASTRUM 
3.1 INTRODUCTION 
3.1.1 Phenolic Compounds 
Phenolic compounds embrace a wide range of compounds that possess an 
aromatic ring bearing one or more hydroxyl substituents including their functional 
derivatives. Compounds that contain several or many phenolic hydroxyl substituents 
are called polyphenols. They are one of the main classes of secondary metabolites 
found in many plants. 
Over the years, plant phenolic compounds have been found to be beneficial in 
human diet and medicines, as they have antioxidant, antiflammatory and 
anticarcinogenic properties. Therefore, investigation of phenolic compounds is very 
important. We were interested in the antioxidative phenolic compounds in the marine 
alga, Sargassum siliquastrum, which was shown to have the strongest antioxidant 
activity among 13 other species found in Hong Kong (Table 2.7 and 2.9). 
3.1.2 Major Classes of Phenolic Compounds 
Approximately 8000 natural phenolic compounds are known to occur in plants. 
About half of this numbers are flavonoids and their derivatives (Francis, 2000). The 
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major phenolic compounds found in plants may be classified into 4 groups (Table 3.1) 
which are distinguished by the number of constitutive carbon atoms in conjugation 
with the structure of the basic phenolic skeleton (Fig. 3.1) (Waterman and Mole, 1994; 
Robards et al, 1999). 
The concentration of phenolic compounds in plants varies greatly between 
different organs of the plant, such as fruits, bark, leaves or heartwood. They also 
depend on the cultivar, maturity, season, growing site, and various other factors such 
as cultivation practices (Francis, 2000). 
3.1.3 Functional Aspects of Phenolic Compounds 
Phenolic compounds are widely distributed secondary metabolites in plants 
which are involved in the defense system of plants. Besides, they are important for 
pharmaceutical and therapeutic application, as well as in food industry. 
3.1.3.1 Functions of phenolic compounds in plants 
There is an increased evidence that phenolic compounds play an important role 
in physiological and ecological effects in plants. For the former aspects, phenolic 
compounds function as antimicrobial agents. They provide resistance from insect bites 
and infection from fungi, bacteria, and viruses. For example, after infection from 
fungus, the plant synthesized a compound, phytoalexins, which could inhibit or retard 
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Figure 3.1 Chemical structure of catechol, gallic acid, quercetin and 
phlorotannin. 
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"Phytoalexin Theory of Disease Resistance in Plants". It states that, phytoalexins are 
absent from healthy plant tissues, but they are produced whenever the plant is invaded 
by a fungus and if produced in high concentration they are toxic to the invader 
(Walker, 1975). 
Phytotoxic phenols are chemicals secreted by the plant. They may be autotoxic 
or suppress the growth of other plants in the environment (Walker, 1975). Phenolic 
compounds in plant leaves, for example tannins are distasteful to animals. Therefore, 
they have useful role as feeding deterrents, which protect plants from overgrazing by 
many animal species (Swain, 1977). 
Another ecological role for phenolics are plant pollination. Anthocyanins and 
flavonoid pigments found in flowers and fruits are responsible for some colours. These 
colour pigments can attract animals or insects such as bees to plants for pollination 
and seed dispersal (Harborne, 1993). 
3.1.3.2 Biological and pharmacological activities 
Phenolic compounds have received attention with its interesting biological 
activities and medicinal applications. They are known to possess antioxidant activity, 
which has the ability to scavenge reactive oxygen species and free radicals, thereby 
preventing ageing, protecting against cardiovascular disease and neurodegenerative 
process (Francis, 2000; Morton et al., 2000). They also act as antimicrobial agents. 
Abram and Donko (1999) demonstrated that polyphenols from Sempevivum tectorum 
exhibited antimicrobial effect on the growth of seven microorganisms. Staphylococcus 
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a爾ns (94.5%) and Bacillus cereus (92.1%) showed the most growth inhibition in the 
presence of leaves from Sempevivum L. 
Besides, phenolic compounds are also responsible for antitumor, antiviral and 
anti-inflammatory activities. Hydrolyzable tannin monomers, oligomers and 
galloylated condensed tannins exhibited antiviral activity against herpes simplex virus 
(HSV) in vitro. The activity was shown to be due to the inhibition o f H S V replication 
by blocking the virus adsorption to the cultured cells (Okuda et al, 1992). Oral 
administration of green tea polyphenol was reported to inhibit ultraviolet B light-
induced tumor formation in mouse skin (Conney et al, 1992) and N_ 
nitrosodiethylamine- induced tumorigenesis in mouse lung (Wang et al, 1992). 
Masuda and Jitoe (1994) found that curcuminoids from Zingiber cassumunar has anti-
inflammatory properties, which can inhibit edema formation in mouse ear induced by 
inflammatory inducer, 12-0-tetradecanoylphorbol 13-acetate. 
3.1.3.3 Food industry 
The importance of phenolic substances in food technology are their colour, 
taste and flavour in many foods and drinks. For example, the anthocyanin pigments 
from grape skins are responsible for the colour production of red wine (Francis, 2000). 
Anthocyanin pigments are abundant in many fruits, and since they are natural 
colorants, food manufacturers prefer them to make colour of the products. It was 
reported that approximately 10,000 tons of grape anthocyanins are utilized annually 
(Francis, 2000). 
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While chlorogenic acids and tannins contribute to the astringent and bitter 
sensation in beverages (Walker, 1975; Francis, 2000), they are important in the 
development of beer flavour and the formation of haze. Flavonoids such as naringin 
are responsible for the bitterness in citrus juices. Thus, they have considerable 
potential in the food industry as safe and effective food additives. 
3.1.4 Polyphenolic compounds in brown algae 
Phenolic compounds found in brown algae have been known for a long time. 
They are apparently localized in intracellular vesicles called physodes (Ragan and 
Jensen, 1977). The polyphenol compounds in brown algae are all derived from simple 
C6 precursor phloroglucinol (1,3,5-trihydroxybenzene) and its polymers, which are 
often referred to as phlorotannins (Ragan and Glombitza, 1986). The phloroglucinol 
units are linked together to form a series of polyphloroglucinols of low (10^ -
intermediate (10^ - 10"^ ) and high (>10^^ amu) molecular weights (Mclnnes et al., 1984). 
Phenolic content in brown algae is reported to vary from 0% in Laminarian digitata to 
about 15% of dry weight in Halidrys siliquosa and Fucales vesiculosus (Ragan and 
Jensen, 1977; Ragan and Glombitza, 1986). Phenolics are readily extruded and are 
abundant in the Fucus "juice" that is released when Fucus is kept in the plastic bag 
(Ragan and Glombitza, 1986). 
Polyphenol content of brown algae may be influenced by external and internal 
factors，e.g. salinity of seawater, seasonal variation, presence of predators and 
infection with parasites. Pederson (1984) demonstrated that phenolic content of A. 
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nodosum and F. vesiculosus increased with increasing age of tissue and with 
increasing salinity. Joshi and Godwa (1975) showed that low salinity of seawater 
caused by the July-August monsoon rains decreased the polyphenol level of Indian 
Sargassum ilicifolium. Polyphenol level is also affected by seasonal changes. Ragan 
and Jensen (1978) showed a significant temporal correlation between polyphenol 
content and the reproductive state of the algae. In A. nodosum, polyphenol content was 
decreased throughout its ' fruiting season' and increased during the period of 
maximum shedding of fruit bodies (May/June). They reached their maximum during 
the winter season in October, when the algae accumulated levels of mannitol， 
laminarian and alginate. In F. vesiculosus, the polyphenol level was minimum in late 
June, just before the period of maximum fertility, and thereafter reached a maximum 
during the period of sterility in winter. 
Nevertheless, polyphenol levels vary between different members of brown 
algae and from geographical setting. Gorham and Lewey (1984) reported that the 
polyphenol content of S. muticum was highest during the summer, with maximum 
during the period of fertility, which was in contrast with the result reported by Ragan 
and Jensen (1978) which stated that the polyphenol content was higher during the 
winter. 
The ability of brown algal polyphenols to chelate heavy metals has been 
known for many years (Ragan and Glombitza, 1986). They are able to chelate heavy 
metals with different affinities. Pederson (1984) showed that A. nodusum and F. 
vesiculosus had the highest affinity for copper. The copper content accumulated in all 
tissues and was significantly higher at the highest salinity than at the lower ones. 
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As in terrestrial plants, phenolic compounds in brown algae provide an 
important function in deterrence of herbivores. Steinburg (1985) had shown that 
phenolic-rich algae had consistent deterrent or inhibitory effects against intertidal 
gastropods, Tugus tegula and many other species of marine herbivores. Besides, they 
could also inhibit colonization by epiphytic algae and animals (Ragan and Glombitza, 
1986). 
Phenolic compounds of brown algae possess antibacterial and antifungal 
activity (Sieburth and Conover, 1965; Ragan and Glombitza, 1986). They have the 
ability to seal off the injured region to prevent bacterial infection by precipitating 
proteins of the algae or that of the invader. Phenolic compounds can also inhibit the 
growth of various algae (Fletcher, 1975) and toxic to a variety of marine animals 
(Ragan and Glombitza, 1986). 
3.1.5 Objectives 
Various studies have demonstrated the antioxidative property of phenolic 
compounds from marine algae. Recently, the active compounds were identified as 
fucoxanthin in Hijikia fusiformis (Yan et al, 1999) and phlorotannins in Sargassum 
kjellmanianum (Yan et aL, 1996). When screening 13 species of marine algae in Hong 
Kong, we have found that the methanol extract of siliquastrum exhibited the most 
potent antioxidative activity (Table 2.7 and 2.9). Therefore, in continuation of the 
work, S. siliquastrum was selected for the isolation and identification of potent and 
effective algal phenolic antioxidants from its methanol extract. 
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Antioxidant activity of the isolated compounds were determined using the 
inhibition of RBC hemolysis, suppression of lipid peroxidation using rat brain 
homogenate, and scavenging of superoxide radical. The amounts of total phenolic 
compounds were also determined in order to establish a relationship between the 
phenolic content and the antioxidative activities of the extracts. 
3.2 METHODS AND MATERIALS 
3.2.1 Extraction and Isolation of Antioxidant Components from S. siliquastrum 
S. siliquastrum was rinsed with fresh water and frozen. The frozen alga was 
lyophilized before extraction. Dry algal sample was milled into small pieces. Ten 
grams of algal sample was extracted with 150ml methanol in a soxhlet extractor for 6 
hrs. The extraction was repeated twice. The solvents were combined and evaporated 
under reduced pressure to a dark green semisolid, extract which was then dissolved in 
distilled water and transferred to a separating funnel. The suspension was partitioned 
successively in 3 different solvents, dichloromethane, ethyl acetate and n-butanol in 
this order. This is to fractionate into polar and non-polar compounds. The organic 
solvents of each of the four extractions was evaporated to dryness in the rotary 
evaporator to give the dichloromethane fraction, ethyl acetate fraction, butanol 
fraction and water fraction, respectively. They were kept in dark and stored at 4°C 
under nitrogen. 
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From the antioxidation assays (Table 3.3 and 3.4)，it was found that the 
dichloromethane fraction contained the most active antioxidant compounds. Therefore 
this fraction was further purified for antioxidant compounds. The dichloromethane 
fraction was subjected to a liquid column chromatography packed with silica gel 60 
(70-230 mesh, Merck). Elution was performed with chloroform : methanol in the 
following ratio; 99:1，95:5, 90:10，80:20, 50:50 successively. The eluate was 
combined according to TLC analytical results to produce 4 separated sub-fractions, F l , 
F2, F3 and F4. Solvent was removed under a stream of nitrogen gas, and the yield and 
antioxidant activity of each sub-fraction was determined. 
3.2.2 Thin-Layer Chromatography (TLC) 
Thin-layer chromatography was performed on silica-gel plates (5x20cm, 
Kieselgel 60F, 0.25mm, Merck). An aliquot of each fraction was spotted on silica gel 
plate with a solvent system of chloroform/ ethanol/ acetic acid/ water (98:10:2:2 v/v). 
The spots were visualized by spraying the plates with 3 sprayer (Adegoke and Krishna, 
1998): 
Spray 1: A 1% solution of potassium ferricyanide in water and a 1% solution of 
ferric chloride in water. 
Blue colour produced indicates the extracts may be phenolic compounds. 
Spray 2: Two percent of ferric chloride in ethanol. 
Blue colour produced indicates probably the presence of trihydroxyl 
phenolic compounds. 
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Spray 3: Ammoniacal silver nitrate solution. Thirty milliliters of ammonium 
hydroxide mixed with 70ml water. Silver nitrate (3.4g) dissolved in 
100ml water was then added to the solution. Sprayed plate was heated for 
lOminat 105°C. 
Brown, black, and gray spots produced indicate they are reducing 
compounds. 
3.2.3 Antioxidant Activity 
The antioxidant activity of all fractions and sub-fractions was determined by 
the hemolysis assay (2.2.3), lipid peroxidation assay (2.2.4) and superoxide radical 
scavenging activity (2.2.2) as described in details in Chapter 2. 
3.2.4 Determination of Total Phenolics 
The concentration of total phenolic compounds in the extracts was determined 
spectrophotometrically using Folin-Ciocalteu reagent (Julkunen-Tiito, 1985). The 
seaweed extracts (0.1ml) on a flask was diluted with deionized water (7.9ml). Folin-
Ciocalteu phenol reagent (0.5ml) was added and the contents of the flask were mixed 
thoroughly. After 1 min，1.5ml of 20% sodium carbonate solution was added and the 
mixture was mixed thoroughly. The mixture was allowed to stand for 1 hour. The blue 
colour produced was measured with a spectrophotometer at 750nm. Phenolic content 
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was expressed in mg/g of dry weight (extract powder) based on standard curve for 
gallic acid (GA), which was expressed as mg/g GAE (gallic acid equivalent). 
3.2.5 Infrared Spectra (IR) 
IR of all the sub-fractions were recorded in potassium bromide (KBr) discs 
with Fourier-transform IR spectrophotometer. One milligram of dry sample was 
mixed with lOOmg of dry KBr and the mixture was pressed into a disc. The whole IR 
spectrum (500-4000cm'') was recorded on a Nicolet Magna 750 FT-IR 
spectrophotometer. 
3.2.6 Ultra-violet and visible (UV-vis) Spectrophotometry 
UV-vis absorption of the subfractions in ethanol was recorded in a Milton Roy 
spectrophotometer. 
The bathochromic shift of the absorption maxima was determined by adding 2 
drops of a 2M solution of sodium hydroxide to the test sample in cuvette. The 
absorption maxima was then recorded (Waterman and Mole, 1994). 
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3.2.7 Statistics 
The results are expressed as mean 土 S.E.M. Data were analyzed with 
SigmaStat software. Analysis of variance (ANOVA) and Student- Newman- Keuls 
Test were used to assess significant differences (p<0.05) between fractions. 
3.3 RESULTS 
3.3.1 Identification of phenolic compounds from various solvent extracts of 
siliquastrum 
The yields and the colours of fractions obtained from the methanol extract ofS. 
siliquastrum separated by different solvents are given in Table 3.2a. The antioxidant 
activities of each fraction were determined using hemolysis assay, lipid peroxidation 
assay and superoxide radical scavenging, and the results are shown in Tables 3.3, 3.4, 
and 3.5, respectively. Dichloromethane fraction appeared to possess stronger 
antioxidant activity (p<0.05) than the crude methanol extract at 10昭/ml in hemolysis 
assay initiated by AAPH (Table 3.3). However, it did not show a dose-dependent 
relationship. The inhibitory effect of dichloromethane fraction was also significantly 
higher (p<0.05) than the positive control, BHA and vitamin C except at 50jig/ml. 
Among the 4 fractions, water fraction showed the weakest inhibitory effect againsi 
RBC hemolysis. 
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Table 3.2a Yields (dry weight) and colours of extracts obtained by 
solvent fractionation from the methanol extract of S. siliquastrum. 
Solvent Yield % Appearance of fraction 
Dichloromethane 58.9 dark-green semisolid 
Ethyl acetate 3.21 green semisolid 
Butanol 7.96 light-brown powder 
Water 22.1 reddish-brown powder 
Table 3.2b Yields (dry weight) and colours of fractions obtained by silica gel 
column chromatography from the dichloromethane fraction of S. siliquastrum . 
Fraction Yield % Appearance of fraction 
Fl 27.1 green semisolid 
F2 11.5 green semisolid 
F3 16.3 green semisolid 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In lipid peroxidation assay, dichloromethane fraction also exhibited the highest 
antioxidant activity among the 4 fractions (Table 3.4) and its activity was significantly 
higher (p<0.05) than the crude methanol extract and the control, BHA. All of the 
fractions showed a dose-dependent manner. At the concentration of 0.08|Lig/ml, 
dichloromethane fraction exhibited 86% inhibition of the lipid peroxidation induced 
by FeSCVascorbic acid. Similar to the hemolysis assay, water fraction exhibited very 
little activity on lipid peroxidation. Butanol fraction had 96.3% inhibitory effect at a 
concentration of 250|ag/ml as compared to the water fraction which showed little 
activity (data not shown). 
All of the fractions had little effect on superoxide radical scavenging activities 
(Table 3.5). The scavenging activity were less than 20% even at a concentration of 
20|ig/ml. 
Figure 3.2 shows the TLC chromatogram of the 4 fractions and crude methanol 
extract after sprayed with potassium ferricyanide/ferric chloride solution. Crude 
methanol, extract, dichloromethane and ethyl acetate fraction produced 2 blue spots 
indicated that these fractions contain 2 types of phenolic compounds. These three 
fractions also produced 2 gray spots on TLC plate after sprayed with ammoniacal 
silver nitrate solution which indicated the presence of reducing properties in the two 
phenolic compounds identified (data not shown). However, when sprayed with 
ethanolic ferric chloride solution all fractions did not give blue spot, indicated the 
absence of trihydroxyl phenolic compounds in all the fractions (data not shown). The 
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Figure 3.2 TLC chromatography of different fractions isolated f rom 
methanol extract of S. siliquastrum by solvent extraction. 1: methanol 
extract; 2: dichloromethane; 3: ethyl acetate; 4: butanol; 5: water 
fraction. Plate was sprayed with 1% solution of potassium ferricyanide in 
water and 1% solution of ferric chloride in water. Phenolic compound 
gives a blue spot on plate. Solvent system: chloroform - ethanol - acetic 
acid - water (98:10:2:2 v/v). 
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Table 3.6a The Rf value and the colour of different fractions from S. siliquastrum 
methanol extract on TLC plate. Plate was sprayed with spray 1 (1% of potassium 
ferricyanide and ferric chloride) and spray 2 (ammoniacal silver nitrate solution) to 
identify the phenolic compounds and reducing compounds, respectively. 
Spray 1 Spray 2 
Fractions colour Rf colour Rf 
Crude methanol blue 0.86,0.75 grey 0.90，0.79 
yellow 0.84 dark green 0.86 
Dichloromethane blue 0.85,0.75 grey 0.87,0.76 
yellow 0.82 yellowish green 0.83 
ethyl acetate light blue 0 .85,0 .73 light grey 0.86 
grey 0.75 
yellowish green 0.82 
Butanol light blue 0.02 grey 0 
Water - - -
Table 3.6b The Rf value and the colour of different fractions of dichloromethane 
fraction from S. siliquastrum on TLC plate. 
Spray 1 Spray 2 
Fractions colour Rf colour Rf 
Dichloromethane blue 0.90，0.79 grey 0 .88,0 .78 
yellow 0.87 yellowish green 0.85 
F1 blue 0.88 grey 0.86 
F2 -
F3 blue 0.78 grey 0.76 
yellow 0.84 yellowish green 0.83 
F4 blue 0 .82 ,0 .76 grey 0.80，0.77 
orange 0.87 orange 0.86 
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3.3.2 Isolation of dichloromethane fraction by liquid chromatography 
Since dichloromethane fraction had the highest antioxidant activity, it was 
further purified using liquid chromatography. The yields and the colours of the 
fractions (Fl - F4) obtained are given in Table 3.2b. According to TLC analytical 
results and after spraying the plates with spray 1 (Fig. 3.3) and spray 3, Fl and F3 
contained 1 phenolic compound with reducing properties while F4 contained 2. The Rf 
value of these fractions are shown in Table 3.6b. 
The antioxidant activities of these sub-fractions were carried out. As shown in 
Table 3.7, there was no significant difference (p>0.05) between F3 and 
dichloromethane fraction in hemolysis assay. However, Fl and F2 have a better 
(p<0.05) protective effect against RBC hemolysis (82% and 69% inhibition, 
respectively), than that of dichloromethane fraction (9.9%) at a concentration of 
50|ig/ml. 
In Table 3.8，at a concentration of 0.016|ig/ml, Fl exhibited over 60% 
inhibition of lipid peroxidation, which was significantly (p<0.05) higher than that of 
dichloromethane fraction. F l , F3, and F4 seemed to exhibit higher antioxidant activity 
than the control, BHA. F2 showed the weakest inhibitory effects. All of the 4 sub-
fractions and dichloromethane fraction were relatively less effective in scavenging of 
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Figure 3.3 TLC chromatography of different fractions isolated from 
dichloromethane fraction of S. siliquastrum by silica gel column 
chromatography. 1: dichlorometha fraction; 2: sub-fraction 1; 3: sub-
fraction 2; 4: sub-fraction 3; 5: sub-fraction 4. Plate was sprayed with 
1% solution of potassium ferricyanide in water and 1% solution of 
ferric chloride in water. Phenolic compound gives a blue spot on 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.3.3 Phenolic content of isolated compounds 
Table 3.10 shows the data corresponding to the levels of total phenolics in 
different fractions of S. siliquastrum after purification. While F3 (80.0mg/g GAE) 
contained the highest amount of phenolic content, the water fraction had the lowest 
amount (28.95mg/g GAE). The phenolic content of F3 and F4 were significant higher 
(p<0.05) than the dichloromethane fraction. 
There was no correlation between the total phenolic content and the 
antioxidant activity of the fractions in all assays. F1 which efficiently protected 
against RBC hemolysis and suppressed lipid peroxidation did not contain the highest 
total phenolic content. F3 which only had a moderate antioxidant activity contained 
the highest phenolic content. 
3.3.4 IR and UV-vis spectra 
Figure 3.4 shows the IR spectrum of F l . The IR spectrum indicated the 
presence of hydroxyl groups (3415 cm' ') , aromatic ether stretch (1260，1100, 1025 
cm])，aromatic CH stretching (2850-2970, 1470 cm])，aromatic ketones (1725 cm' ') , 
tetrasubstituted aromatic i.e. two neighboring H-atoms (800-850 cm' ') , aromatic ring 
(1620 cm' ') , and aliphatic aldehyde (1385 cm]) . The IR spectrum of F3 was similar to 
that of Fl (data not shown). While for F2 and F4，the spectram did not show the 
aldehyde group (1385 cm' ' ) and aromatic ketones (1725 cm"'), respectively (data not 
shown). 
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UV absorption spectra in ethanol of the sub-fractions and dichloromethane 
fraction was shown in Table 3.11. UV spectral data of F l , F3 and F4 indicated a 
similar absorption maximum at 298nm, but F2 did not. F l and F4 showed an 
additional absorption maxima at 404 and 450nm, respectively. F2 had an absorption 
maximum at 296nm. There was a bathochromatic shift of the absorption maxima of 
the fractions after adding sodium hydroxide solution (Table 3.11). The wavelength of 
the absorption maxima, 298nm in F l , F3 and F4 was changed to 314nm (Fig. 3.5b). 
However, the peak maxima of F4 (450nm) split to two absorption peaks at X 426 and 
450nm (data not shown). 
8 7 
Table 3.10 Polyphenol content of different fractions from S. siliquastrum. 
Total polyphenol are expressed as gallic acid equivalent (mg/g GAE). 
Fractions GAE • 
Methanol 51.0 士 2.15 a 
Dichloromethane 62.2 士 0.86 ^ 
Ethyl Acetate 64.1 土 0.33 b 
Butanol 33.0 士 1.64 ' 
Water 28.9 土 3 . 7 1 ' 
F1 50.7 士 1.41 a 
F2 29.8 ± 1.07 e 
F3 80.0 士 0.95 d 
F4 71.2 ± 3.75 e 
* Each value is the mean 士 S.E.M (n=3). Means within column 
with different superscript letters differ significantly (p<0.05). 
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Figure 3.4 IR spectrum of fraction 1 isolated from S. siliquastrum. 
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Table 3.11 UV spectra data of different fractions isolated from dichloromethane 
fraction of siliquastrum. Bathochromic shift reagent (sodium hydroxide) was 
added to identify the phenolic peak of which the absorption maxima was changed. 
Fractions X max (nm) bathochromic shift * X 腿(nm) 
Dichloromethane 298, 410，667 314, 401, 665 
F l 298,404 314 ,401 
F2 296 307 
F3 298 314 
F4 298，450 315，426，450 
* When bathochromic shift reagent (sodium hydroxide) was added, the 
wavelength of the absorption maxima of a peak corresponding for a phenolic 
compound would shift to a longer A. 
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Figure 3.5a UV spectrum of F1 isolated f rom S, siliquastrum. 
j 
； 0.375 





O ] 0.115 
P n，J 248 ！ ^ 
b 0 . � ] G.113 ； 
^ ] 222, i 
n : I I i 1 0.071 
c - lUi J . i y ！ 條 0.030 
I f ！ \ 509 536 613 丄 
o.oW'V ' 、 、 一 " ^ 乂 
i ’ 
I ' j ' ' ' " • ' ' ' 1 ' 1 ' ' ' i • ' j , • . I ' ' . 1 I 1 I • . ' . I i i j . I . . ! I . . I 
ZOO 30G 4GG 500 6GG 7G0 8G0 
Manometers 






^ 0 叫 / \ 
b ： O.IIS I \ 
s 247 I 1 
° 0.221! I I 
r 2Z1 / \ 
‘ 0 . 2 � j J, 
a , 1 . 1 1 \ 
: I f K : 
0.0-* I � ~ 
I ' ' ' ' " " " … T , ' I I I I I I i u _ I ' , … I I . , , I I I . , 1 … . ~ I . I I I I I , I I . . . . . . J 




3.4.1 Antioxidative activities 
Three assays, namely inhibition of RBC hemolysis, suppression of lipid 
peroxidation using rat brain homogenates and superoxide radical scavenging，have 
been used to measure the antioxidant activity of the methanol extract and the different 
components isolated by differential solvent extraction from the methanol extract as 
well as by liquid chromatography from S. siliquastrum 
Hemolysis of rat RBC induced by peroxyl radical initiator, 2,2’-
azobis(amidinopropane)dihydrochloride (AAPH) was used in this study. As shown in 
Table 3.3, butanol and water fractions did not show any protective effect on RBC 
hemolysis. On the other hand, dichloromethane fraction showed the strongest 
protective effect which had 79% inhibition at a concentration of 10|ig/ml compared 
with the other fractions and the methanol extract. This suggests that the potent 
antioxidant components tend to be more soluble in a non-polar solvent, such as 
dichloromethane. However, the antioxidant activity in terms of inhibition of RBC 
hemolysis was not concentration dependent. This may be explained by the fact that at 
a high dosage, toxic substances present in the extract might cause RBC hemolysis. 
Another probability is that there might be chemical substances in the dichloromethane 
fraction acting as a pro-oxidant, which involves in the initiation reactions, as 
dichloromethane fraction was very susceptible to oxidation. 
All fractions were also assayed by the determination of Fe^Vascorbate induced 
lipid peroxidation in the rat brain homogenate. As shown in Table 3.4, all fractions 
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produced dose-related inhibition of lipid peroxidation, with dichloromethane fraction 
exhibiting considerable suppressive activities against Fe^Vascorbate induced lipid 
peroxidation even at a concentration of 0.08ng/ml. The inhibition of lipid peroxidation 
of the dichloromethane extract was about 10 times stronger than the methanol extract 
at 0.08 and 0.4|Lig/ml. The results of lipid peroxidation assay are in good agreement 
with those obtained by the hemolysis assay, where the inhibitory effects of the 
fractions were in the order of dichloromethane > ethyl acetate > butanol > water. In 
both assays, the activity of dichloromethane fraction was observed to be stronger than 
that of BHA at the same concentration. Among the fractions tested，the water fraction 
exerted the weakest antioxidant activity in both assays. 
The above results were inconsistent with the results of Lee et al (1996), who 
reported that the ethyl acetate fraction of brown algae exhibited a stronger antioxidant 
activity than that of the dichloromethane fraction. However, it is difficult to compare 
the antioxidant ability with others from literature data, because different methods were 
employed in the extraction and analytical procedures. 
Since the dichloromethane fraction exerted effective inhibitory effects on both 
RBC hemolysis and lipid peroxidation, it was inferred that the potent antioxidant 
component(s) should be non-polar compounds. Moreover, the dichloromethane extract 
gave strong antioxidative activities and higher yields than the other fractions. 
Therefore, the dichloromethane fraction might be useful in food industry for 
protection against lipid peroxidation in foods, because the low polarity of this 
component enable it to be readily dissolved in the lipid fraction of the food. 
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Attempt was made to isolate the active antioxidant compound from the 
dichloromethane fraction by liquid chromatography. Four sub-fractions (F1-F4) were 
obtained. It was found that F1 and F2 were more effective as an antioxidant in 
protection of RBC hemolysis than the dichloromethane fraction, but the effect was 
more pronounced in F1 (Table 3.7). At high concentration, both fractions (F1 and F2) 
did not produce toxic effect to RBC, and their antioxidant activity showed a 
concentration-dependent manner. Although F3 showed the highest activity at a 
concentration of lOjig/ml, which was similar to dichloromethane fraction, F1 had the 
most significant contribution to protect RBC against AAPH radical as F3 would be 
toxic to RBC at high concentration. 
Concerning lipid peroxidation assay, F1 exerted the strongest activity, while 
F3 and F4 had only moderate activity. F2 was the least active in preventing lipid 
peroxidation (Table 3.8). The inhibitory effect of F1 on lipid peroxidation was 
observed to be stronger than dichloromethane fraction, and also about 3 fold stronger 
than that of BHA. This indicates that F1 isolated from S. siliquastrum is very effective 
in inhibiting lipid peroxidation. 
Based on both experimental assays, F1 markedly inhibited lipid peroxidation 
induced by Fe^Vascorbate and protected RBC attacked by peroxyl radical. F1 
contained non-polar compound(s) as it was the first eluted fraction from the column. 
Antioxidants can be classified into two groups, namely primary or chain-
breaking antioxidants, and secondary or preventive antioxidants. F1 isolated from S. 
siliquastrum exerted strong protection for RBC against hemolysis and potent 
inhibition of rat brain lipid peroxidation. However, it had very little effect on 
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superoxide radical scavenging activity. It therefore acts as a chain-breaking 
antioxidant. 
3.4.2 Relationship between phenolic contents and antioxidant activity 
It is well known that plant phenolic compounds may act as antioxidants. They 
act through different mechanisms: via free radical scavenging, hydrogen donation, 
singlet oxygen quenching, metal-ion chelation or as substrate for attack by superoxide 
(Robard et al, 1999). 
The content of total phenolics was determined according to Folin-Ciocalteu 
method. It is a commonly used method for measuring total phenolics. It is a reduction-
oxidation reaction in which the phenolate ion is oxidized under alkaline conditions 
while reducing the phosphotungstic-phosphomolybic complex in the reagent to a blue-
coloured solution (the chromophore) (Waterman and Mole, 1994). This method is 
nonspecific for any phenolic compound and the colour yielded depends on the number 
of hydroxyl groups and their location in the molecules. 
As seen in Table 3.10，the methanol extract gave high phenolic content in the 
dichloromethane and ethyl acetate fractions, i.e. 62.2mg/g GAE and 64.12mg/g GAE, 
respectively. The level of phenolic content was low in the butanol and water fractions. 
Fractionation of dichloromethane fraction gave a significantly higher amount of 
phenolic compounds in F3 (80mg/g GAE) compared to F2 which possessed the least 
phenolic content (29.76mg/g GAE). 
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In this study, we have found no correlation between the total phenolic content 
and the antioxidant activities of the various fractions from the dichloromethane extract. 
F l exhibited the strongest antioxidant activity in both hemolysis and lipid 
peroxidation assays, but its phenolic content was less than that of F3 and F4. 
Therefore, the antioxidant activity of the fraction cannot be predicted on the basis of 
its total phenolic content alone. Heinonen et al (1998a) reported that there was no 
correlation between the total phenolic content and the antioxidant activity of the berry 
and fruit wines. As many fruits and berries contain high amounts of anthocyanins that 
responded poorly in the Folin-Ciocalteu assays, this assay did not accurately respond 
to the true antioxidant nature of the phenolic constituents (Heinonen et al” 1998a). 
Since Folin-Ciocalteu reagent is non-specific, there may be some interference 
substances present in the fraction, such as sugars, polypeptides and ascorbic acid to 
affect the absorbance readings (Waterman and Mole, 1994). The fact that there was no 
correlation between the total phenolic content and the antioxidant activity may also be 
explained by the different composition of phenolic compounds, which might respond 
differently in the Folin-Ciocalteu assay. While the active components in Fl which 
exhibit efficient antioxidant action do not necessarily correlate with high amounts of 
phenolic, other substances such as ascorbic acid and sugar can also play a role to 
affect the absorbance. 
The alternative techniques for quantification of phenolic compounds are using 
high performance liquid chromatography (HPLC) and gas chromatography gas 
spectrometry (GC/MS) (Waterman and Mole, 1994). The compounds were quantified 
by using the standard curves of the authentic standards. HPLC and GC/MS can even 
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purify and identify the individual phenolic compounds in the samples. Therefore, they 
are commonly used technique to quantify and qualify the phenolic compounds. 
3.4.3 Identification of antioxidative compounds 
Identification of antioxidative compounds from S. siliquastrum was based on 
thin-layer chromatography (TLC), infrared spectrum (IR) and ultraviolet-visible (UV-
vis) spectrum. 
The crude methanol extract of S. siliquastrum was fractionated into 4 fractions. 
These fractions were separated by TLC and identified by visualizing plates with 3 
spray reagents. It was found that after spraying TLC plate with spray 1，active 
compounds appeared as a blue spot, which indicated the presence of a phenolic 
compound. Two blue spots were observed in the methanol extract, dichloromethane 
and ethyl acetate fractions, which had strong antioxidant activities and high total 
phenolic content. In addition, spraying with spray 3 gave 2 gray spots in the methanol 
extract, dichloromethane and ethyl acetate fractions. Based on the Rf values shown in 
Table 3.6a, the antioxidant components of methanol extract, dichloromethane and 
ethyl acetate fractions were tentatively identified to be phenolic compounds with 
reducing properties. A yellow spot, (Rf： 0.82, 0.84)，was visible on the TLC plate in 
the methanol extract and dichloromethane fractions, indicating the possible presence 
of carotenoid compound. 
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According to Lee et al. (1996), phenolic compounds, phloroglucinol extracted 
f rom brown algae, Ecklonia stolonifera showed a strong antioxidant activity. Yan et al 
(1996) also found that phlorotannins isolated from Sargassum Jg'llmamanum could 
prevent fish oil f rom rancidification and had antioxidant activity higher than that of 
BHT. 
The dichloromethane fraction was further isolated by liquid chromatography 
and gave 4 sub-fractions according to TLC analysis. As seen in TLC plate sprayed 
with spray 1 (Fig. 3.3)，all 4 sub-fractions of the dichloromethane extract was well 
separated. F l and F3 contained 1 phenolic compound with Rf value 0.88 and 0.78, 
respectively, while F4 appeared to contain 2 phenolic compounds with Rf value 0.82 
and 0.76. A yellow-orange pigment was also isolated in the F4 with Rf value 0.87. The 
hemolysis and lipid peroxidation assays revealed that F l was the most effective 
antioxidant, and F2 was the least. This was supported by the TLC analysis that F2 did 
not produce a blue spot indicating the absence of phenolic compound. At least 4 types 
of phenolic compounds were identified from S. siliquastrum with higher antioxidant 
activity than that of BHA, based on different Rf values and colour of the spray. 
According to UV/vis spectra (Table 3.11), the 4 sub-fractions (F1-F4) 
contained different components despite some fractions contained similar absorption 
maxima. Modify ing reagents such as sodium hydroxide (NaOH) were used to confirm 
the peak to be phenolic compound. Shifting of the wavelengths of absorption maxima 
to a longer one was observed. This effect is known as a bathochromatic shift caused 
by the ionization of the phenol with the production of the corresponding phenolate ion 
(Waterman and Mole, 1994). Igile et al (1994) used other shift reagents, aluminium 
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chloride and sodium acetate to confirm the location of the hydroxyl groups of the 
flavonoid by UV spectra. The present study suggested that the absorption maxima of 
F l , F3 and F4, had a bathochromatic shift (16nm) with NaOH, confirming the 
presence of phenolic compound(s) (Fig. 3.5b). The phenolic compound(s) in F2 and 
F3 were different because the bathochromatic shifts were 11 and 16nm, respectively. 
The presence of hydroxyl group and aromatic ring in the IR spectrum of the 4 
sub-fractions also suggested the presence of phenolic compounds. However, the 
spectra were difficult to be used to interpret the structure of the compounds in the 
fraction unless they were compared with an authentic standard. 
It was found that despite all of the sub-fractions contained phenolic 
compounds and their IR spectrum were quite similar, they had significantly different 
antioxidative activities. The difference of the activities among them might be due to 
the structural differences. This is because antioxidant activity is closely related to the 
position and the number of hydroxyl groups of the molecules (Robards et al” 1999). 
The antioxidative effectiveness of the compounds increases with increasing number of 
the hydroxyl groups, which have the ability to scavenge free radicals by donating 
hydrogen atoms to lipid radicals. Ogata et al. (1997) reported that the phenolic 
compounds with hydroxyl groups at the ortho or para position had antioxidant activity 
greater than that of compounds with 2 hydroxyl groups at the meta position. 
A number of studies have shown that the marine algae extracts and its 
polyphenols have antioxidant activity. The phenolic compounds in brown algae are 
derived from phloroglucinol and its derivatives (Ragan and Jensen, 1977). Yan et al 
(1999) reported that the major active compound from brown seaweed, Hijikia 
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fusiforms was identified as fucoxanthin. Cahyana et al. (1992) showed that 
pyropheophytin a, was one of the chlorophyll a-related compounds in Eisenia biscyclis 
had an antioxidative activity higher than that of a-tocopherol using TBA method. 
Recently，phlorotannin was isolated as an active antioxidant component from 
Sargassum kjellmanianum and Ecklonia stolonifera (Lee et al” 1996; Yan et al, 1996). 
Based on the IR spectrum, the antioxidative compounds of the sub-fractions 
may contain phloroglucinol unit (Ragan and Jensen, 1977), as they have aromatic ring, 
hydroxyl groups and aromatic ether link (1260cm-'). However, their structure might 
differ slightly in the number and position of hydroxyl group and ether group, which 
would affect the antioxidative activities of the compounds. Since each sub-fraction 
displayed certain degrees of antioxidative activity, suggesting that several components 
are involved in the antioxidative activities of the S. siliquastrum extract. 
Four sub-fractions were isolated from dichloromethane fraction by silica gel 
column chromatography. Based on the TLC analysis, F l , F3 and F4 were identified to 
have phenolic compounds with reducing properties. Four phenolic compounds were 
observed with different Rf values. These sub-fractions had a bathochromatic shift 
shown in UV spectra and the presence of hydroxyl group and aromatic ring shown in 
IR spectrum, suggesting the presence of phenolic compounds in the fractions, which 
were in agreement with the TLC results. 
With regard to the total phenolic content measured by Folin-Ciocalteu method, 
the amount of total phenolic content in the sub-fractions varied from 29 to 80mg/g 
GAE with F3 containing the highest amount. 
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The four isolated sub-fractions exhibited potent antioxidative activities. They 
all showed excellent activity in protecting RBC against hemolysis and inhibiting lipid 
peroxidation with F l being the most effective. They had relatively higher antioxidant 
activity than that of BHA and vitamin C in the hemolysis assay, but F3 and F4 showed 
some toxic effect to RBC. They also had exceptionally higher antioxidant activity than 
BHA in the lipid peroxidation assay, with an exception of F2 that had activity 
comparable to BHA. However, the present study did not show a correlation between 
the total phenolic content of the fractions and their antioxidant activity. 
On the basis of the results，Fl of the dichloromethane fraction from the 
methanol extract of S. siliquastrum contained the most potent antioxidant phenolic 
compounds, which is a non-polar and non-toxic chain-breaking antioxidant. There is 
no report so far on the study of the antioxidant activity of the methanol extract of S. 
siliquastrum and its active components. Therefore, these findings would be very 
useful. This active component may have the potential in the development of 
therapeutic product to protect against certain diseases. In addition, it has a potential to 
be used as a natural antioxidant in food industry especially with respect to stabilize 
foodstuffs by retarding and extending shelf life. 
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CHAPTER 4 
HYPOTENSIVE ACTIVITIES OF MARINE ALGAE IN THE RAT 
4.1 INTRODUCTION 
Cardiovascular disease is a leading cause of death throughout the world. 
Hypertension or high blood pressure especially is a major risk factor, affecting 
approximately 20% of the adult population of developed countries. Hypertension often 
leads to lethal complications such as stroke, heart and kidney disease，atherosclerosis 
and others (Lawrence et al., 1996). In Hong Kong, approximately one in 12 men and 
one in 16 women had borderline hypertension [140-159mmHg (systolic pressure) and 
/or 90-94mmHg (diastolic pressure)] (Janus et al., 1997). Treatment of hypertension is 
usually life-long, and therefore the drugs should be effective and safe over a long 
period. 
4.1.1 Basic Principles of Cardiovascular System 
The cardiovascular system consists of the heart, the blood vessels, and 
regulatory mechanisms that control their functions. The functions are to convey blood 
throughout the body, to render adequate supply of nutrients and oxygen to all tissues, 
to remove the waste products of cellular metabolism from all tissues, and to conduct 
hormones from one part of the body to another (Smith and Kampine, 1990; Guyton 
and Hall, 1997). The circulation is divided into systemic circulation, which transports 
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oxygen and nutrients to all tissues of the body, and pulmonary circulation, which 
delivers blood to the lungs for the elimination of carbon dioxide and the acquisition of 
oxygen. Approximately 84% of the entire blood volume of the body is in the 
systematic circulation. 
Every one has a blood pressure, which is necessary to circulate blood through 
arteries and provide tissues with oxygen. If the brain and heart did not receive 
adequate blood for a few minutes, there will be a serious and fatal outcome. Blood 
pressure (BP) means the force exerted by the blood against any unit area of the vessel 
wall (Guyton and Hall, 1997). It is almost always measured in millimeters of mercury 
(mmHg). Blood flow is pulsatile. The pressure at the highest of each pulse being 
achieved by the heart contracts is known as systolic pressure (SP), while diastolic 
pressure (DP) is defined as the lowest pressure reached of each pulse, which is the 
pressure in the circulation when the heart is not contracting. However, blood pressure 
varies with age, sex and socio-racial grouping. The normal blood pressure for young 
adults are 120mmHg systolic and 80mmHg diastolic (Guyton, 1980). The difference 
between systolic and diastolic pressure is the pulse pressure (PP). Mean arterial 
pressure (MAP) is the average pressure that exists in the aorta and major branches over 
the duration of a cardiac cycle (Opie, 1997). It is closer to the diastolic than systolic 
pressure because diastole normally accounts for a longer period than systole. For 
convenience MAP may be taken as the diastolic pressure plus one-third of the pulse 
pressure (MAP = DP + 1/3 (PP)). 
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The blood pressure is determined by cardiac output (CO) and total peripheral 
resistance (TPR). CO is the product of stroke volume (SV) and heart rate (HR) 
(Sperelakis and Banks, 1996; Opie, 1997). 
BP = CO X TPR 
CO = SV X HR 
Cardiac output is the total volume of blood ejected per minute from each ventricle. It is 
about 5000ml per min in an adult person. SV is the quantity of blood ejected by the 
heart in each beat. Four factors influence the SV and they are diastolic filling, 
contractility of the heart, aortic pressure (afterload) and heart rate (Smith and Kampine, 
1990). Total peripheral resistance is the impediment to blood flow through the vessel, 
which is directly proportional to the viscosity of the blood and inversely proportional 
to the diameter of the blood vessels. Therefore, any conditions of the circulation that 
affects either of these factors will also affect the blood pressure. For example, during 
heavy exercise, the BP rises about 30 to 40%, which results mainly from the following 
effects. The increase in cardiac output is obligatory, in order to meet the increased 
need for oxygen and nutrients by the exercising muscle. Stroke volume is also 
increased due to both an increased in diastolic filling with a resultant increase in the 
force of ventricular contraction (Smith and Kampine, 1990). Despite the rise in BP by 
these factors, there are multiple neural control mechanisms that operate all the time to 
return BP to its normal value. These mechanisms will be discussed in the following 
sections. 
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4.1.2 Regulation of Arterial Pressure 
Effective control of arterial pressure requires coordinated interaction between 
the vasculature and heart. Otherwise, dramatic fluctuations of arterial pressure would 
occur. The autonomic nervous system and central nervous system are involved in the 
regulation of arterial pressure, the former being the most well-understood. The control 
is supplied by a combination of 2 major regulatory systems (1) short term (seconds) 
adjustments are intended to correct temporary imbalances of arterial pressure, and (2) 
long term (minutes to days) adjustments are intended to change the blood volume and 
indirectly affect arterial pressure. 
4.1.2.1 Short-term regulation of arterial pressure 
Short-term regulation is governed by 4 nervous reflex responses. 
(1) Arterial baroreceptor reflex 
The baroreceptor reflex is the most important nervous mechanism for short-
term control of arterial pressure. The baroreceptor reflex is initiated by stretch 
response. They are found in abundance in the walls of each internal carotid artery, 
known as carotid sinus，and in the wall of the aortic arch (Guyton and Hall, 1997; 
Mohrman and Heller, 1997). The stretch receptors sense a rise in pressure indirectly 
from the degree of stretch of the elastic arterial wall, which causes them to transmit 
signals into the central nervous system, and send back "feedback" signals through the 
autonomic nervous system to the circulation to lower the arterial pressure back to the 
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normal level. The signals transmitted inhibit the activity of sympathetic nerves to the 
heart, and therefore cause a decrease in cardiac output and peripheral resistance and a 
fall in blood pressure, due to both arterial and venous dilation and to the decreased 
force of cardiac contraction (Guyton, 1980; Guyton and Hall, 1997). This reflex is 
important during changes in body posture e.g. when a person stands up after having 
been lying down. Therefore, the baroreceptor reflex is function as a 'buffer ' , 
stabilizing the blood pressure against acute change. 
(2) Chemoreceptor reflex 
The chemoreceptors are located mainly in the carotid and aortic bodies, which 
are small, highly vascularized nodules adjacent to the carotid sinus and aortic arch 
(Levick, 1995). Chemoreceptors are sensitive to lowered oxygen tension (pO�)，raised 
carbon dioxide tension (PCO2) in blood and increased in arterial concentration. The 
main purpose of this reflex is to stimulate respiratory minute volume, and also increase 
oxygen delivery to the brain and heart through peripheral vasoconstriction and 
increased arterial pressure (Smith and Kampine, 1990). This is caused by the signals 
transmitted from the chemoreceptor into the vasomotor center, which excite the 
vasomotor center and thus increase the arterial pressure (Guyton and Hall, 1997). The 
chemoreceptor reflex is important in certain pathophysiological situations such as the 
hypoxia of altitude (low arterial pO�）and circulatory shock (peripheral ischaemia). 
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(3) Low pressure receptors 
Low pressure receptors are stretch receptors which can be formed in the atria, 
the pulmonary arteries, and endocardium ventricular. They are important in 
minimizing arterial pressure changes in response to changes in blood volume. 
Therefore, a raise in blood volume e.g. transfusion, will send signals to the brain to 
inhibit sympathetic outflow and to decrease the release of renin, which would decrease 
the peripheral vascular resistance and lessens the increase in blood pressure. They 
elicit reflexes parallel to the baroreceptor reflexes to make the total reflex system much 
more potent for the control of arterial pressure (Guyton and Hall, 1997; Opie, 1997). 
(4) Central nervous system (CNS) ischemic response 
CNS ischemic response is a reflex in response to cerebral ischemia to increase 
the arterial pressure. It is activated only when the arterial pressure falls below 
60mmHg, and becomes progressively more active at a pressure of about 15mmHg. 
The main purpose is to act as emergency arterial pressure control system that acts as 
rapidly and extremely powerful to prevent further decrease in arterial pressure 
whenever blood flow to the brain decreases dangerously close to the lethal level 
(Smith and Kampine, 1990; Guyton and Hall, 1997). 
4.1.2.2 Long-term regulation of arterial pressure 
In the long-term regulation of arterial pressure，the mechanisms are operated 
from the changes in blood volume and in the patterns of the urinary excretion of 
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sodium and water. It is important to maintain a normal extracellular fluid volume and 
sodium mass. The kidneys play a major role in this control. 
Renal-body fluid system is important to maintain a constant level of arterial 
pressure (Guyton and Hall, 1997; Mohrman and Hellen, 1997). Changing in blood 
volume is accompanied with the changes in total body fluid volume, as blood volume 
is part of the total body fluid. An increase in extracellular fluid causes increased 
arterial pressure. The rising in arterial pressure in turn has a direct effect to cause the 
kidneys to excrete the excess extracellular fluid (increase urine output rate) and 
therefore a decrease in blood volume, and eventually the arterial pressure will return to 
the normal level. It takes hours or even days to adjust blood pressure all the way back 
to its original level. 
When the arterial pressure falls too low, renin is released by the kidneys. This 
leads to an increase in formation of angiotensin and aldosterone, which in turn 
promotes renal sodium reabsorption and decreased renal output rate, and eventually 
returns blood pressure to normal. 
Thus，regulation of arterial blood pressure is involved in several interrelated 
control systems. Some are important in buffering acute changes in arterial pressure, 
while others are slowly acting through body fluid balance. 
4.1.3 Hypertension 
Elevation of the blood pressure is a widespread condition in many populations. 
Since blood pressure rises steadily with age, it is difficult to set the dividing line 
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between normal and high blood pressure. The World Health Organization (WHO) 
defines hypertension as blood pressure which exceeds 160 (systolic) / 95 (diastolic) 
mmHg and values of 140 to 160 / 90 to 95 mmHg considered as borderline 
hypertension in adults (Hurst et al., 1978; Genest et al., 1983). However, for elderly 
patient age over 75, blood pressure of 170/100 mmHg might be regarded as an 
acceptable normal level. 
In the great majority of high blood pressure patients (>90%), raised blood 
pressure has no underlying cause, and is termed essential hypertension. It is believed 
that the condition is a multifactorial genetic disorder, in which inheritance of a number 
of abnormal genes predisposes someone to raise blood pressure, and also result under 
the influence of environmental factors (high salt diet, pyschosocial stress). While in 
small minority (<10%) of patients who have high blood pressure with a disease known 
to be its cause is termed secondary hypertension. When the underlying disease is 
treated, the hypertension may be reduced (Smith and Kampine, 1990). 
4.1.3.1 Causes of hypertension 
There are several different factors and processes contribute to the development 
of hypertension. Hypertension is manifested when one or more factors of the 
regulatory system undergo a functional defect, and thus the system can no longer 
compensate the elevated blood pressure to normal levels. 
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1) Renin- angiotensin- aldosterone systems 
Reduced blood flow in kidney is known to activate the juxta-glomerular 
apparatus and set off the renin-angiotensin systems. When renal blood flow is reduced 
and so the renal arterial pressure, these cause the release of renin from the 
juxtaglomerular cells into the circulation. Release of renin stimulates angiotensin I 
formation and this in turn is converted to angiotensin 11. Angiotensin II is a powerful 
vasoconstrictor and also induces aldosterone secretion, a hormone that promotes 
reabsorption of sodium by the kidneys, and is thought to account for the hypertension 
in renal conditions (Kincaid-Smith and Whitworth, 1982; Smith and Kampine，1990; 
Salerno, 1999). 
The relationship between renal disease and hypertension has been recognized 
for over a century. The two renal diseases most commonly cause of secondary 
hypertension are renovascular hypertension and renal parenchymal hypertension. 
Renovascular hypertension is caused by an obstruction of one or both renal arteries, 
due to atherosclerosis plaques or fibromuscular dysplasias. This disease would 
increase the release of renin following constriction of renal arteries and eventually 
increase blood pressure (Genest et aL, 1983; Smith and Kampine, 1990). Renal 
parenchymal disease is affected by pyelonephritis (inflammation and scaring of the 
kidney tubules) or chronic glomerolonephritis (inflammation and scarring of the 
glomeruli). It is thought that the underlying cause is a decreased renal perfusion due to 
inflammatory and fibrotic changes (Kincaid-Smith and Whitworth, 1983; Smith and 
Kampine, 1990). 
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2) Endocrine diseases 
There are several endocrine disorders associated with hypertension: 
a) Pheochromocytoma 
Pheochromocytoma is an adrenal medullary tumor which arises from 
chromaffin cells. They secret adrenaline and noradrenaline into the blood 
stream，which cause stimulation of sympathetic tone and chronic peripheral 
vasoconstriction, and lead to a rise in blood pressure (Smith and Kampine, 
1990). 
b) Primary aldosteronism 
Oversecretion of aldosterone from tumor in adrenal gland leads to increased 
sodium reabsorption and potassium excretion, and hence, aldosterone-induced 
hypertension is characterized by sodium and potassium ions imbalance. Also, 
increased renal sodium reabsorption results in volume expansion and elevated 
blood pressure (Genest et al., 1983). 
c) Cushing's syndrome 
Hypertension occurs in Cushing's syndrome arises from the effects of adrenal 
overproduction of glucocorticoids and mineralocorticoid. This is due to 
increased adrenocorticotrophic hormone (ACTH) production by adrenocortical 
adenoma, carcinoma, or, possibly, hypothalamic dysfunction. These may cause 
sodium and water retention, which may contribute to the pathogenesis of the 
hypertension (Genest et al, 1983). 
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3) Neurogenic theory 
Stimulation of the sympathetic nervous system may contribute to acute 
hypertension. For instance, emotional stress lead to elevated sympathetic tone, 
peripheral vasoconstriction occur in the body, and acute hypertension ensues (Guyton， 
1991). 
Another type of acute neurogenic hypertension occurs when the nerves leading 
from the baroreceptors are cut or when the tractus solitarius is destroyed in each side 
of the medula oblongata (Guyton, 1991). These patients commonly displayed 
tachycardia and have an increased cardiac output and increased blood pressure (Smith 
and Kampine, 1990). 
Some investigators believe that acute hypertension can cause chronic 
hypertension due to abnormalities of the nervous system. DeQuattro et al (1969) 
demonstrated that although plasma noradrenaline concentrations in rabbits returned to 
normal after surgery, tissue levels of noradrenaline were not changed. Alterations in 
noradrenaline metabolism after surgery are consistent with increased sympathetic tone 
during the onset of neurogenic hypertension. According to Guyton (1991)，after 
sectioning the baroreceptor nerves, sympathetic nervous system became extremely 
activated. Renal blood f low is decreased to extremely low levels because of severe 
renal vascular vasoconstriction. This can cause permanent damage to the kidneys that 
can possibly lead to a prolonged renal type of hypertension. 
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4) Atherosclerosis and hypertension 
Development of atherosclerosis (narrowing of coronary artery) is closely linked 
to the pathogenesis of hypertension. Atherosclerosis is a result of damage to the 
vascular endothelium and deposition of lipoprotein in the vascular walls, which is 
known to be accompanied by activation of lipid peroxidation in blood. The process of 
atherogenesis begins when circulating low-density lipoprotein (LDL) particles move 
across the endothelium into the arterial wall where they are subjected to oxidation by 
local cells. After oxidative modification, the LDL particles are rapidly taken by 
macrophages with foam cell formation. Foam cells accumulated to form fatty streaks 
and these can develop into arterial plaques resulting in a narrowing of arterial lumens 
(Maxwell and Lip, 1997). As a result of the increase in the vascular resistance of these 
arteries，coronary flow is reduced and eventually leads to hypertension (Genest et al, 
1983). With continued pressure elevation, the atherosclerosis will become severe, with 
consequent death from heart attacks and strokes. 
5) Miscellaneous causes 
Hypertension related to oral contraceptives is usually mild and reversible. Both 
estrogen and progesterone appear to be responsible for the blood pressure elevation, 
via renin-angiotension system activation and hyperinsulinaemia (Genest et al, 1983). 
Women who have hypertension during pregnancy are more likely to develop 
sustained essential hypertension in later years than those who are normotensive. 
Hypertension during pregnancy is caused by the thickening of the glomerular 
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membranes (perhaps caused by an autoimmune process), which reduces the rate of 
fluid filtration from the glomeruli into the renal tubules (Guyton, 1991). 
Fat people tend to have higher blood pressure than people of normal weight. 
However, the mechanism is poorly understood. Ellison et al. (1980) found that obese 
adolescents used more salt in relation to calories than their lean counterparts. Obese 
people tend to have higher cardiac output due to their greater body mass and blood 
volume (Opie，1998). Hall et al. (1996) reported that this might be due to the 
activation of the adrenergic system in obesity. 
Besides，age, sex, race and heredity contribute to the development of 
hypertension. Blood pressure rises steadily with age. Tonkin and Wing (1994) reported 
that this was due to the loss of the buffer functions of the aorta as its elasticity 
decreased, and the increased intraluminal aortic pressure resulting from the increase of 
peripheral vascular resistance with age. The incidence of hypertension in women has 
been found to be less than in men. Hypertension is approximately twice as widely in 
black as in whites (Genest et al, 1983). Genetic factors also play an important part in 
the development of essential hypertension (Genest et al, 1983). 
4.1.3.2 Where do antihypertensive or hypotensive agents act? 
Hypotension agents used for the control of blood pressure are derived from a 
number of classes. They have the same properties to reduce the blood pressure but 
accomplish this through several unrelated mechanisms of action. 
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4-1.3.2.1 Sympathetic nervous system inhibitors 
The autonomic nervous system plays a major role in the regulation of 
cardiovascular function. It has two divisions, the sympathetic and parasympathetic, 
which are present in most body of the structures and have opposing actions on 
activation. Both divisions originate in nuclei within the central nervous system and 
give off efferent preganglionic fibres, which terminate in ganglia. The preganglionic 
neurotransmitter for both divisions is acetylcholine which diffuses across the synapse 
to act on nicotinic receptors on the postganglionic neuron. The postganglionic 
neurotransmitters for the sympathetic system are noradrenaline and adrenaline, while 
parasympathetic system is acetylcholine. These neurotransmitters interact with 
receptors on the effector organ to elicit a response (Rang and Dale, 1991; Opie, 1997). 
Sympathetic adrenergic stimulation is achieved by a combination of 
noradrenaline and adrenaline, which act on cardiac p-adrenergic receptors to enhance 
contractility and heart rate, and a-adrenergic receptors to increase the tone of arterioles. 
On the other hand, parasympathetic or cholinergic system acts through the vagal nerve 
to release acetycholine that causes a decrease in cardiac rate and force of contraction. 
Therefore，adrenergic inhibiting agents are effective in reducing blood pressure. There 
are different sites of these drugs act to influence the sympathetic pathway (Fig 4.1). 
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a) p-adrenergic blockers 
p-adrenergic blocking drugs are widely used agent in the treatment of 
hypertension. There are two subtypes of (3-receptor, |3, and p2. Pi-receptors have 
stimulatory effects that are found mainly in the heart, while Pz-receptors caused 
vasodilation in arterioles, p-blockers are drugs that competitively antagonize the 
effects of the noradrenaline and adrenaline on cardiac P-adrenergic receptors (Brody et 
al., 1998). They can reduce the heart rate, force of contraction, and cardiac output. 
Atenolol, sotalol, nadolol, propranolol, metaprolol and penbutolol are examples of p-
blockers. 
The mechanisms by which (3-blockers produce a reduction in BP in 
hypertension patient is not completely understood. However, the proposed 
mechanisms may include, reduction of sympathetic activity, reduction in cardiac 
output，and reduction in renin release (Theoharides，1996; Brody et al., 1998). 
P-blocker drug is an effective and well tolerated agent, therefore, it is 
commonly used as a first-line agent in the management of high blood pressure. 
Unfortunately, half of the patients have some potential problems with their 
administrations, which include, bradycardia, heart failure, bronchospasm and central 
nervous system disturbances (Frishman, 1995; Theoharides, 1996). 
b) a-adrenergic blockers 
Similar to P-adrenergic receptors, a-adrenergic receptors also have 2 subtypes, 
(Xi and a2. a , - receptors are found in vascular smooth muscle and exert 
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vasoconstriction effects, while a : - receptor are located on the terminals of sympathetic 
neurons that reduce the release of catecholamine (Frishman, 1995). 
a-adrenergic blockers cause vasodilation and a fall in blood pressure because 
they prevent adrenaline and noradrenaline from stimulating the vascular a-receptor to 
produce vasoconstriction, a-blocker drugs were the first adrenergic blockers to be 
developed for cardiovascular therapy. The a-blockers can be divided into two groups, 
nonselective, that is, block both the a , - a n d o t r receptor, and selective, that is only a , -
receptors are blocked. Phentolamine, phenoxybenzamine, prazosin and tetrazosin are 
examples of a-blocker drugs. Prazosin is a selective a , -blocker and is widely 
employed a-blocker in the treatment of hypertension (Antonaccio, 1990; Craig and 
Stitzel，1997). This is because it can cause vasodilation and lower blood pressure, but 
prevent the increased noradrenaline release from sympathetic nerves, which would 
occur if presynaptic a2-receptors were also blocked with nonselective blockers such as 
phentolamine. 
The reflex tachycardia is a serious effect of nonselective a-blockers. The most 
commonly encountered side effects of selective a , -b locker are postural hypotension, 
headaches and dizziness. 
c) Centrally acting adrenergic inhibitors 
Centrally acting adrenergic inhibitors act within the central nervous system by 
stimulation of central a2-receptors, which reduce the flow of impulses through the 
sympathetic neurons to the blood vessels and the heart. Blood pressure is reduced by 
decreasing cardiac output, heart rate, and peripheral vascular resistance (Salerno, 
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1999). The effective centrally acting hypotensive agents are clonidine and a -
methyldopa, which are used for the treatment of primary hypertension and moderate 
hypertension, respectively. Administration of these drugs causes sodium and water 
retention and plasma volume expansion, and therefore they are not used alone (Craig 
and Stitzel, 1997). Their side effects include sedation, drowsiness, dry mouth and 
headaches. 
d) Adrenergic neuron-blockers 
Guanethidine and reserpine are two examples of the adrenergic neuron-
blocking agents. However, their actions are slightly different. Guanethidine inhibits the 
release of noradrenaline from postganglionic adrenergic nerve endings, and 
subsequently depletes the stores of noradrenaline. Whereas, reserpine causes the 
depletion of noradrenaline stores by blocking the uptake system of the amine storage 
granules (Rang and Dale, 1991; Antonaccio, 1990). They exert their hypotensive 
effects by reducing sympathetic peripheral vasoconstriction, as well as cardiac output 
and heart rate. The severe adverse effects of guanethidine include postural hypotension, 
diarrhea and weakness. While for reserpine, they include depression, ulcers and nasal 
congestion. These drugs are not commonly used currently because of their severity of 
the adverse effects (Theoharides, 1996; Salerno, 1999). 
e) Ganglionic blockers 
Ganglionic blocking drugs have the ability to block autonomic ganglia and 
interfere with the transmission of nerve impulses from preganglionic nerve terminals 
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to the cell bodies of postganglionic neurons. They prevent the interaction of 
acetylcholine (preganglionic neurotransmitter) with nicotinic receptors on postsynaptic 
neuronal membranes of both the sympathetic and parasympathetic nervous systems 
(Brody et al, 1998). This causes BP fall mainly from blocking the sympathetic ganglia, 
which cause arteriolar vasodilation and reduce cardiac output. Severe postural 
hypotension, blurred vision, and urinary retention are the resultant side effects (Rang 
and Dale, 1991). Hexamethonium and trimethapan are ganglionic blocking drugs, but 
they are in limited use. 
4.1.3.2.2 Diuretics 
Diuretic drugs are widely used in the therapy of mild-to-moderate hypertension. 
Diuretic drugs produce a fall in BP by increasing the excretion of urine, so excess salt 
and water will be lost from the body by an action on the kidney. However, the 
mechanism by which diuretics lower BP is not entirely understood. Administration of 
diuretics produces a drop in BP, which is caused by a decreased in cardiac output 
resulting from a fall in extracellular and plasma volume and followed by a decrease in 
peripheral vascular resistance by dilating the arterioles in lowering the BP (Craig and 
Stitzel，1997; Salerno, 1999). 
There are three groups of diuretics: thiazides diuretics (chlorothiazide, 
hydrothiazide)，loop diuretics (furosemide, ethacrynic acid) and potassium-sparing 
agents. They all are commonly used today because they are free of side effects. 
1 2 0 
However, when administered chronically, diuretics (except potassium-sparing agent) 
may produce hypokalemia (low plasma potassium). 
4.1.3.2.3 Vasodilators 
Vasodilators are extremely potent agent for acute treatment of hypertensive 
crises and heart failure. Hydralazine, diazoxide and sodium nitroprusside are examples 
of vasodilator drugs. Vasodilators produce a direct relaxation on vascular smooth 
muscle of the arterioles and/or veins, and result in vasodilation. This leads to a 
decrease in peripheral resistance and BP (Craig and Stitzel, 1997; Salerno, 1999). This 
reduction in BP stimulates the sympathetic nervous system and activates the 
baroreceptor reflexes. The increase in sympathetic tone will lead to increased heart rate, 
cardiac output, and increase renin secretion. A transient tachycardia, and water and 
sodium retention are frequently observed, which are the expression of a reflex 
mechanism responding to the fall in BP. For these reasons, it is only used in combined 
therapy with other antihypertensive drugs, and not used for treatment of chronic 
hypertension (Frishman, 1995). 
4.1.3.2.4 Calcium antagonist (Calcium channel blockers) 
Calcium channel blockers reduce BP by blocking the movement of calcium 
ions into arterial muscle cells，with a resulting inhibition of excitation-contraction 
coupling of the muscle and causes dilation of the arterioles. This would decrease the 
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peripheral resistance and so as the BP (Frishman, 1995). Examples of calcium channel 
blockers are verapamil, nifidipine and filtiazem. Side effects include headache, 
dizziness, fainting, orthostatic hypotension and etc. 
4.1.3.2.5 Angiotensin-converting enzyme (ACE) inhibitors 
Angiotensin-converting enzyme inhibitors block the conversion of angiotensin 
I to angiotensin II by inhibiting angiotensin-converting enzyme primarily in the lungs. 
Angiotensin II causes vasoconstriction of arterioles and lead to high BP. Therefore, by 
blocking the production of ACE may (1) decrease vascular tone, thereby directly 
lowering BP; (2) inhibit the release of aldosterone, and reduce sodium and water 
retention; (3) increase in plasma renin activity, caused by a loss of negative feedback 
on renin release (Theoharides, 1996; Salerno, 1999). Captopril, enalapril and lisinopril 
are examples of ACE inhibitor drugs. They are relatively less side effects than other 
antihypertensive drugs unless large doses are used. They also produce unwanted 
effects including dry cough, dizziness, skin rashes etc. 
4.1.3.2.6 Antihypertensive drug combination 
Many drugs are available for the treatment of hypertension. However, when 
they are used alone for a long-term basis, they often exert adverse reactions or 
inadequate efficacy. Therefore using combinations of two or three drugs are needed. 
For example, vasodilator drugs and diuretics (e.g. thiazide) are usually used as 
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combined therapy. Vasodilator drugs can cause sodium and water retention, and 
tachycardia by stimulating sympathetic nervous system, while using diuretic agents 
tend to counteract the side effects of vasodilator drugs. 
4.1.4 The relationship between hypertension and free radicals 
It is believed that hypertension is caused by increased generation of reactive 
oxygen species. Endothelium derived vascular factor (EDRF), also known as nitric 
oxide (NO), is involved in the regulation of vascular tone, inducing the relaxation of 
smooth muscle cells through the activation of the guanylate cyclase (Rice-Evans and 
Bruckdorfer，1995). Nitric oxide is released by endothelial cells upon stimulation by 
vasodilators such as acetylcholine. Therefore damage of endothelial cells would lead 
to changes in peripheral vascular resistance and facilitate the development of 
hypertension. There is evidence suggesting that hypertension associated with 
inhibition of NO synthesis (Schnackenberg et al” 1997). They found that continuous 
administration of a competitive inhibitor of NO production led to sustained 
hypertension. The increase in blood pressure could be partially reversed upon 
discontinuing the inhibitor and could be prevented by simultaneous administration of 
L-arginine (the substrate for nitric oxide synthase). 
Superoxide radicals have been shown to affect vascular resistance by 
inactivating NO (Gryglewski et al, 1986). Polymorphonuclear leukocytes (PMNs) 
which can generate free radicals, are in close proximity to endothelial cells. This 
would inactivate N O and contribute to the elevation of blood pressure. Kumar and Das 
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(1993) demonstrated that both superoxide and hydrogen peroxide production by PMNs 
and the plasma levels of lipid peroxides were higher in uncontrolled essential 
hypertension compared with normal controls. They also found that the concentrations 
of antioxidants such as vitamin E and superoxide dismutase, and NO were decreased 
in patients with uncontrolled hypertension. Swei (1997) reported that the hypertension 
in the Dahl rat is associated with increased production of superoxide radicals by the 
endothelium and increased plasma hydrogen peroxide levels. The plasma hydrogen 
peroxide and mean arterial pressure were found to be correlated. This is to say, free 
radicals are directly contributed to the elevation of blood pressure through inactivation 
o f N O . 
4.1.5 Development of new antihypertensive agents 
It can be seen that the available antihypertensive agents produce various 
unwanted effects. Attempts to develop new types of antihypertensive drugs with 
minimal or no side effects continues to be a focus of intense research. In the present 
study，marine algae extracts were used, as they possess antioxidant activity and other 
pharmacological properties. Four marine algae, Sargassum angustifolium, S. 
siliquastrum, Hypnea charoides and Enteromorpha sp. were examined in 
normotensive rats. The aim was to study the hypotensive effects of the aqueous and 
methanol extracts of the 4 marine algae and their possible mechanisms of action. 
1 2 4 
4.2 MATERIALS AND METHODS 
4.2.1 Animal Care 
Male normotensive Sprague-Dawley (SD) rats weighing 250-300g were used 
in animal experiments. They were provided by the Laboratory Animals Service Centre 
of The Chinese University of Hong Kong. Animals were maintained under normal 
laboratory conditions (21±2°C, 12-hour light-dark cycle) and allowed standard rodent 
chow and water ad libitum. 
4.2.2 Preparation of the blood pressure measurement in rats (Chiu et al” 1995) 
The rats were anaesthetized with sodium pentabarbitol (50mg/kg body weight) 
intraperitoneally. When the rat was unconscious, it was placed in the supine position 
and fixed on a surgical dissection board with vertical side facing up. A vertical incision 
on the skin from the lower jaw to the upper part of the thorax was made. The tissue 
around the left carotid artery was cleared and a segment of the vessel was exposed. A 
ligature was made on the anterior side of the vessel and the posterior was clamped by a 
blood vessel clamp. A small cut was made just posterior to the ligature and a 
polyethylene tubing PE-50 cannula filled with heparinized saline was inserted and 
secured with surgical thread. The clamp was released. The cannula was connected with 
a pressure transducer (Narco, P-100 B) and a MK-111 Narco Physiograph (Narco 
Instrument, Texas) for blood pressure recording. The external jugular vein was also 
cannulated with polyethylene tubing PE-50 and connected to a syringe for intravenous 
1 2 5 
injection (Fig. 4.2). The temperature of the animals was maintained at 37°C by means 
of a table lamp. Rats were anaesthetized throughout the period of investigation. 
4.2.2.1 Effect of seaweed extracts on arterial blood pressure of rat 
Hypotensive effect of seaweed extracts 
4.2.2.1.1 Single-dose response curve 
Animals were allowed to equilibrate for at least 2 minutes. A bolus injection of 
saline (0.2ml) was given to check the stability of blood pressure. (Further testings were 
done if there was no change in blood pressure when saline was administered). A dose 
of the seaweed extract (dissolved in saline) was injected via external jugular vein in 
volume of 0.1ml and followed by 0.2ml saline flush. When the mean arterial pressure 
(MAP) was returned to the original level, another dose of seaweed extract was applied. 
Doses of 0.1，0.3, 3，10，30 and lOOmg/kg body weight were injected to the rats and 
the MAP changes were recorded respectively. The changes in the MAP were 
calculated as the differences between the steady MAP before and the lowest MAP after 
injection. 
4.2.2.1.2 Cumulative-dose response curve 
The protocol was similar to the above experiment except there was no flushes 
of saline between doses of seaweed extracts. A dose of O.lmg/kg of seaweed extract 
was injected to the rat. After the maximal decrease in the MAP was reached, another 
dose of seaweed extract was applied. Thus, doses of 0.2, 0.7，2, 7, 20 and 70mg/kg 
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Figure 4.2 Cannulation of anaesthetized rat in the carotid artery for blood pressure 
measurement and external jugular vein for intravenous injection of algae extracts. 
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were injected to yield cumulative doses of 0.3，1，3, 10，30 and lOOmg/kg body weight, 
respectively. 
4.2.2.2 Pharmacological blocker studies 
In view of the absence of hypotensive response in some seaweed extracts, the 
effects of blockers were only tested on aqueous and methanol extracts of S. 
angustifolium and methanol extracts of both S. siliquastrum and Enteromorpha sp. The 
mechanism(s) of the hypotensive activity of seaweed extract was studied using various 
blockers, which were well-known to affect blood pressure. The possible involvement 
of autonomic ganglion transmission, a-adrenoceptor, p-adrenoceptor, muscarinic 
receptor，histaminergic receptor and renin-angiotensin system were studied using 
specific blockers of these receptors (Chiu et al., 1995). 
Both aqueous and methanol extracts of S. angustifolium at 8mg/kg were tested 
during the studies, whereas the test doses of both methanol extracts of siliquastrum 
and Enteromorpha sp. were 5mg/kg and 20mg/kg, respectively. 
a) Autonomic ganglion transmission 
Male SD rats were anaesthetized and prepared as outlined in the previous 
section 4.2.2 before. A test dose of seaweed extract was given intravenously (i.v) via 
external jugular vein. The MAP changes observed served as a control. 
Hexamethonium (Sigma, USA), which is an autonomic ganglion blocker was then 
injected i.v at a dose of lOmg/kg. After the MAP was depressed by the blocker and 
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became constant, a same dose of the seaweed extract was given again. The change in 
MAP was recorded and compared with the control. 
b) Aipha-adrenoceptor 
A test dose of seaweed extract was given i.v and the change in MAP was noted 
and served as a control. Methoxamine (Burrouhgs-Wellcome, UK), an a-agonist was 
injected i.v at a dose of 50|ag/kg to observe the pressor response. This was then 
followed by an injection of an a-blockade, phentolamine (Ciba, USA) at a dose of 
2mg/kg. As soon as the MAP became stable, the same dose of methoxamine was given 
again to ensure the blockade effect of the blocker. When the pressor effect was 
blocked，the same test dose of seaweed extract was then administered immediately. 
The change in MAP was recorded and compared with the control. 
c) Beta-adrenoceptor 
The procedure was similar to that of the a-adrenergic blockade. A P-agonist， 
isoproterenol (1.2昭/kg，Sigma) was injected intravenously to observe its hypotensive 
response. A blocker, propranolol (2mg/kg, Sigma), was then given and the p-blockade 
was confirmed by injection with the same dose of isoproterenol. A test dose of 
seaweed extract was then followed and change in MAP was recorded. 
d) Acetylcholine receptor 
The procedure was similar to that of the adrenergic blockade. Acetylcholine 
(Merck) and atropine (Sigma) were used as the agonist and blocker, respectively. A 
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bolus injection of acetylcholine was given i.v at a dose o f 2 ^ g / k g to the rat. A blocking 
dose of atropine, 2mg/kg (Sigma) was then followed. To ensure an effective blockade, 
a same dose of acetylcholine was applied. A test dose of seaweed extract was given 
and compared with a control. 
e) Histamine receptors 
The procedure was similar to that of the adrenergic blockade. An injection of 
histamine (Sigma) was given i.v at a dose of 2^g/kg to observe the hypotensive 
response. Pyrilamine (Sigma) and cimetidine (Sigma), a blocker for HI and H2 
receptors, respectively, were then injected simultaneously at a dose of 15mg/kg each. 
The blockade was examined by injecting the same dose of histamine. A test dose of 
seaweed extract was then followed after the blockade was confirmed. 
f) Renin-angiotensin system 
Rats were prepared for the blood pressure measurement. Another cannulation 
was made at the femoral vein for infusion. The possible interaction of hypotensive 
action of seaweed extract with the renin- angiotensin system was studied using a 
converting enzyme inhibitor, captopril. A test dose of seaweed extract was injected i.v 
and the change in MAP was noted. An effective dose of angiotensin I (40Tig/kg, Sigma) 
was injected. This was followed by an infusion of captopril (lO^g/min/kg) through the 
femoral vein for 30min at 0.077ml/min. The same dose of angiotensin I was given 
after captopril infusion to ensure an effective blockade. A bolus injection of seaweed 
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extract was followed. The MAP change was recorded and compared with those before 
infusion of captoril. 
4.2.3 Statistics 
The results are expressed as mean 土 S.E.M. The statistical analysis was 
performed with Student's r-test. Difference was considered as significant if p is less 
than 0.05. 
4.3 RESULTS 
4.3.1 Hypotensive effects of marine algal extracts 
Figure 4.3 illustrates a physiograph tracing of hypotensive response of the 
normotensive rat after intravenous (i.v) injection of S. angustifolium extract. Maximum 
responses were observed about 1 min after injection, with a drop in both systolic and 
diastolic blood pressure. The effect lasted for about 30 seconds. The BP gradually 
returned to the original level within 4 min. However, the duration of the hypotensive 
response was dependent upon the dosage injected. Injection of aqueous extract of S. 
siliquastrum induced an immediate drop ( - 3 0 sec) in BP, and with a 0.3mg/kg dose, 
the BP returned to original values in about 2 min. But with the concentration of 





















































































































































































































































































































Of the four marine algal extracts tested, intravenous administration of crude 
aqueous and methanol extracts of H. charoides, and aqueous extract of Enteromorpha 
sp., did not produce any hypotensive response in normotensive rats. Figure 4.4 shows 
the effect of an i.v injection of algal extracts on the BP in anaesthetized normotensive 
rats. Both crude aqueous and methanol extracts of S. angustifolium produced dose-
dependent decrease in mean arterial blood pressure (MAP). At a dose of 3, 10 and 30 
mg/kg，the M A P values of both extracts were quite similar. The aqueous extract of 5. 
angustifolium produced 82mmHg fall in blood pressure at a dose of lOOmg/kg, while 
for the methanol extract, it was not detected at this dose due to solubility problems. 
For S. siliquastrum, the methanol extract induced a dose-dependent decrease in 
M A P with maximum drop of 54mmHg at 30mg/kg. However, this was not observed in 
the aqueous extract of S. siliquastrum. At lOmg/kg，the hypotensive effect (59mmHg) 
of the aqueous extract was less than at a dose of 3mg/kg (S lmmHg) . The aqueous 
extract of S. siliquastrum showed a strong hypotensive activity because at a dose of 
0.3mg/kg，it could lower the M A P to 21mmHg as compared to extract of other algal 
species which had no response at this dose. Unfortunately, the aqueous extract killed 
the rats when the dosage of i.v injection reached 30mg/kg. 
While the methanol extract of Enteromorpha sp. produced a 4 0 m m H g drop in 
BP at a dose o f 3 0 m g / k g , the drop in BP could not be measured at a dose of lOOmg/kg 
due to insolubility of the extract. 
1 3 3 
Concentration (mg/kg) 
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_100 丄 •. • - angustifolim (MeOH) 
~A~ S. siliquastrum (Aq) 
^~ S. siliquastrum (MeOH) 
0~ Enteromorpha sp. (MeOH) 
Figure 4.4 Dose - response curve of algae extracts on blood pressure in 
anaesthetized normotensive rats. Values are expressed as mean 土 S.E.M of five 
experiments. 
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According to dose response study, the ED50 of aqueous and methanol extracts 
of S. angustifolium were 6.5 and 8.8mg/kg, respectively, while the ED50 for both 
extracts of S. siliquastrum were 0.6mg/kg and 3.5mg/kg, respectively. For the 
methanol extract of Enteromorpha sp. the EDsowas 18mg/kg. This indicates that the 
aqueous extract of S. siliquastrum was the most potent hypotensive agent and the 
methanol extract of Enteromorpha sp. was the least. 
The aqueous extract of S. siliquastrum produced tachyphylaxis, where the 
hypotensive effect was decreased when the extract was repeatedly infused into the 
same rat (Tarn, et cd., 1986). Therefore, this extract would not be further used for 
pharmacological blocker studies. Tachyphylaxis was not observed in other algal 
extracts. 
4.3.2 Effects of Pharmacological Blockers on MAP 
a) Automonic ganglion transmission 
Hexamethonium was used as an autonomic ganglion blocker. After i.v 
injection of hexamethonium, the hypotensive effects of the methanol extract of S. 
angustifolium, S. siliquastrum and Enteromorpha sp. were significantly different 
(p<0.05) from their control group (Figs. 4.11，4.17，4.23). However, the hypotensive 
effect of the aqueous S. angustifolium extract was 33mmHg after administration of 
hexamethonium, which was not significantly different from that of the control group 
(39mmHg decrease in MAP) (Fig. 4.5). 
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b) Alpha-adrenoceptor blocker 
The depressor response of rats to the methanol extract of S. angustifolium and 
Enteromorpha sp. were mediated through a-adrenergic receptor (Fig. 4.12，4.24). 
Phentolamine, which acted as a blocker, blocked the hypotensive effect of 
methoxamine completely. It had also significantly (p<0.05) reduced the M A P of 
methanol extract of<S. angustifolium and Enteromorpha sp. to 36mmHg and 31mmHg, 
respectively. However, administration of phentolamine did not affect the methanol 
extract of 5： siliquastrum (Fig. 4.18) and aqueous extract of 5. angustifolium (Fig. 4.6). 
c) Beta-adrenoceptor blocker 
Propanolol was used as a p-adrenoceptor blocker. In the presence of propanolol, 
the depressor effect of isoproterenol reduced from 54mmHg to 2 .6mmHg. However, it 
could not block the depressor effect of the methanol extract of Enteromorpha sp. after 
administration of propanolol (Fig. 4.25). Pretreatment of propanolol could 
significantly (p<0.05) reduce the hypotensive response of the methanol extract of S. 
siliquastrum (Fig. 4.19) and S. angustifolium (Fig. 4.13), and the aqueous extract of 
angustifolium (Fig. 4.7). 
d) Cholinergic receptor blocker 
Atropine, a blocker of cholinergic receptor, caused a decrease of 22 土 2 m m H g 
in MAP. It blocked the depressor effect of acetylcholine significantly from 47 土 
3 m m H g to 5 士 0 .7mmHg. Likewise, the effect of the methanol extract of S. 
angustifolium was also significantly (p<0.05) blocked by atropine, where the M A P 
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was reduced from 40 ± 1 to 22 士 3mmHg (Fig. 4.14). However, the hypotensive 
actions of the methanol extract of S. siliquastrum and Enteromorpha sp. (Fig. 4.20 and 
Fig. 4.26), and the aqueous extract of S. angustifolium (Fig. 4.8) were not mediated 
through cholinergic receptor because pretreatment of atropine did not affect their MAP. 
e) Histaminergic receptor blocker 
The hypotensive responses of the methanol extract of S. angustifolium (Fig. 
4.15)，S. siliquastrum (Fig. 4.21) and Enteromorpha sp. (Fig. 4.27)，and the aqueous 
extract of S. angustifolium (Fig. 4.9) were shown to mediate through histaminergic 
receptor. Pyrilamine and cimetidine were the blockers of histamine 1 and histamine 2 
receptors, respectively. In the presence of these blockers, the change in M A P caused 
by histamine reduced from 30 ± 1 to 3 士 0 .6mmHg. The hypotensive effect of all algal 
extracts was significantly (p<0.05) lower than that of their control after the 
histaminergic receptor was blocked. 
f) Angiotensin-converting enzyme inhibitor 
Captopril was used as an angiotensin-converting enzyme inhibitor. Infusion of 
captopril to the rat induced a decrease in M A P of angiotensin I f rom 17.7 土 0.7 to 4.8 
土 0 .6mmHg. However, the depressor effects of the aqueous extract ofS. angustifolium 
(Fig. 4.10) and the methanol extract of S. siliquastrum (Fig. 4.22) were not 
significantly affected by captopril infusion, whereas, there was a significant increase 
(p<0.05) in depressor response of the methanol extracts ofS. angustifolium (Fig. 4.16) 
and Enteromorpha sp. (Fig. 4.28) after infusion of captopril. 
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Figure 4.5 Effect of autonomic ganglion transmission blocking agent on the 
hypotensive action of the aqueous extract of S. angustifolium in anaesthetized 
normotensive rats. Values are expressed as mean ± S.E.M. of five experiments 
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Figure 4.18 Effect of a-adrenergic blocking agent on the hypotensive action of the 
methanol extract of S. siliquastrum in anaesthetized normotensive rats. Values are 
expressed as mean 士 S.E.M. of five experiments. 
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Figure 4.7 Effect of p-adrenergic blocking agent on the hypotensive action of the 
aqueous extract of S. angustifolium in anaesthetized normotensive rats. Values are 
expressed as mean 土 S.E.M. of five experiments. * indicates significant difference 
from the control (p<0.05). 
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Figure 4.18 Effect of a-adrenergic blocking agent on the hypotensive action of the 
methanol extract of S. siliquastrum in anaesthetized normotensive rats. Values are 
expressed as mean 士 S.E.M. of five experiments. 
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Figure 4.9 Effect of histaminergic blocking agent on the hypotensive action of the 
aqueous extract of S. angustifolium in anaesthetized normotensive rats. Values are 
expressed as mean 土 S.E.M. of five experiments. * indicates significant difference 
from the control (p<0.05). 
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Figure 4.10 Effect of angiotensin converting enzyme inhibitor on the hypotensive 
action of aqueous extract of S. angustifolium in anaesthetized normotensive rats. 
Values are expressed as mean 土 S.E.M. of five experiments. 
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Figure 4.11 Effect of autonomic ganglion transmission blocking agent on the 
hypotensive action of the methanol extract of S. angustifolium in anaesthetized 
normotensive rats. Values are expressed as mean 土 S.E.M. of five experiments * 
indicates significant difference from the control (p<0.05). 
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Figure 4.12 Effect of a-adrenergic blocking agent on the hypotensive action of the 
methanol extract of S. angustifolium in anaesthetized normotensive rats Values are 
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Figure 4.13 Effect of P-adrenergic blocking agent on the hypotensive action of the 
methanol extract of S. angustifolium in anaesthetized normotensive rats. Values are 
expressed as mean 土 S.E.M. of five experiments. * indicates significant difference 
from the control (p<0.05). 
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Figure 4.14 Effect of cholinergic blocking agent on the hypotensive action of the 
methanol extract of S. angustifolium in anaesthetized normotensive rats. Values are 
expressed as mean 土 S.E.M. of five experiments. * indicates significant difference 
from the control (p<0.05). � 
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Figure 4.15 Effect of histaminergic blocking agent on the hypotensive action of the 
methanol extract of S, angustifolium in anaesthetized normotensive rats. Values are 
expressed as mean 士 S.E.M. of five experiments. * indicates significant difference 
from the control (p<0.05). 
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Figure 4.16 Effect of angiotensin converting enzyme inhibitor on the hypotensive 
action of the methanol extract of S‘ angustifolium in anaesthetized normotensive rats. 
Values are expressed as mean 士 S.E.M. of five experiments. * indicates significant 
difference from the control (p<0.05). 
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Figure 4.17 Effect of autonomic ganglion transmission blocking agent on the 
hypotensive action of the methanol extract of S. siliquastrum in anaesthetized 
normotensive rats. Values are expressed as mean 士 S.E.M. of five experiments. * 
indicates significant difference from the control (p<0.05). 
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Figure 4.18 Effect of a-adrenergic blocking agent on the hypotensive action of the 
methanol extract of S. siliquastrum in anaesthetized normotensive rats. Values are 
expressed as mean 士 S.E.M. of five experiments. 
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Figure 4.19 Effect of p-adrenergic blocking agent on the hypotensive action of the 
methanol extract of S. siliquastrum in anaesthetized normotensive rats. Values are 
expressed as mean 士 S.E.M. of five experiments. * indicates significant difference 
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Figure 4.20 Effect of cholinergic blocking agent on the hypotensive action of the 
methanol extract of S. siliquastrum in anaesthetized normotensive rats. Values are 
expressed as mean 土 S.E.M. of five experiments. 
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Figure 4.21 Effect of histaminergic blocking agent on the hypotensive action of the 
methanol extract of S. siliquastrum in anaesthetized normotensive rats. Values are 
expressed as mean 土 S.E.M. of five experiments. * indicates significant difference 
from the control (p<0.05). 
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Figure 4.22 Effect of angiotensin converting enzyme inhibitor on the hypotensive 
action of the methanol extract of S. siliquastrum in anaesthetized normotensive rats. 
Values are expressed as mean 土 S.E.M. of five experiments. 
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Figure 4.23 Effect of autonomic ganglion transmission blocking agent on the 
hypotensive action of the methanol extract of Enteromorpha sp. in anaesthetized 
normotensive rats. Values are expressed as mean 土 S.E.M. of five experiments. * 
indicates significant difference from the control (p<0.05). 
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Figure 4.24 Effect of a-adrenergic blocking agent on the hypotensive action of the 
methanol extract of Enteromorpha sp. in anaesthetized normotensive rats. Values are 
expressed as mean 土 S.E.M. of five experiments. * indicates significant difference 
from the control (p<0.05). 
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Figure 4.25 Effect of P-adrenergic blocking agent on the hypotensive action of the 
methanol extract of Enteromorpha sp. in anaesthetized normotensive rats. Values are 
expressed as mean 士 S.E.M. of five experiments. 
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Figure 4.18 Effect of a-adrenergic blocking agent on the hypotensive action of the 
methanol extract of S. siliquastrum in anaesthetized normotensive rats. Values are 
expressed as mean 士 S.E.M. of five experiments. 
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Figure 4.27 Effect of histaminergic blocking agent on the hypotensive action of the 
methanol extract of Enteromorpha sp. in anaesthetized normotensive rats. Values are 
� p r e s s e d as mean 土 S.EM, of five experiments. * indicates significant difference 
from the control (p<0.05). 
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Figure 4.28 Effect of angiotensin converting enzyme inhibitor on the hypotensive 
action of the methanol extract of Enteromorpha sp. in anaesthetized normotensive 
rats. Values are expressed as mean 士 S.E.M. of five experiments. * indicates 
significant difference from the control (p<0.05). 
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4.4 DISCUSSION 
4.4.1 Hypotensive effects of the marine algal extracts 
The aqueous and methanol extracts of S. angustifolium and S. siliquastrum, and 
methanol extract of Enteromorpha sp. possessed a hypotensive activities in 
normotensive anaesthetized rats via intravenous injection (Fig. 4.4). This was in 
agreement with the results of Chiu and Fung (1997)，who showed the hypotensive 
effects of Laminaria japonica with a decreased in blood pressure of lOOmmHg at a 
dose of lOOmg/kg in normotensive rat. Ren et al (1994) also reported the 
antihypertensive effects of 26 species of marine algae. Porphyra yezoensi was the most 
potent which reduced the blood pressure nearly 9 0 % of the control level on the 28出 
day of feeding. Besides marine algae, other edible mushroom such as Pleurotus sajor-
cajor (Tarn et al., 1986)，Volvariella volvacea (Chiu and Lam, 1995), and Tricholoma 
mongolicum (Wang et al., 1996) have been reported to be hypotensive in normotensive 
rats. 
The aqueous and methanol extracts of S. angustifolium and S. siliquastrum, and 
the methanol extracts of Enteromorpha sp. induced a fall in MAP with different 
potency. The hypotensive activity was greatest in the aqueous extract of S. 
siliquastrum compared to the other extracts, which has a ED50 of0 .6mg/kg. At a dose 
of 0.3 and Img/kg, it produced a significant decrease in MAP, 21.07 土 3.30 and 58.13 
土 2.68mmHg，respectively. However, there was no response or little response to blood 
pressure change on other extracts at these dosages. 
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The hypotensive effects of all 4 extracts were dose-dependent except the 
aqueous extract of siliquastrum. According to Tarn et al (1986)，tachyphylaxis was 
observed with decreasing hypotensive effect when extract was repeatedly infused into 
the same rat. Calixto et al (1986) also observed tachyphylaxis in rat treated with 
repeated administration of Img/kg of tannic acid at 20min interval. There was no 
hypotensive effect after the fifth infusion of tannic acid. This tachyphylaxis 
phenomenon also occurred in the aqueous extract of S. siliquastrum, in which the 
activity of higher dosage was lower than that of the lower dosage. Tachyphylaxis was 
also observed in this extract at a lower concentration (0.3mg/kg), when the same dose 
was repeatedly injected. Because of this reason, this extract would not be tested for 
pharmacological blocker studies. Although the aqueous extract oi S. siliquastrum was 
the most potent one, it could kill the rat at a dose o f 3 0 m g / k g indicating the presence 
of some toxic substances. 
As shown in Figure 4.3, the maximum hypotensive response occurred within 1 
min after injection. The effects were brief (~30sec), and followed by a gradual 
recovery to the original level within 4 min. The duration of the response and recovery 
depend upon the extracts and the dose injected. The immediate hypotensive response 
after i.v injection of the extracts indicated a direct action of these extracts on the 
cardiovascular system. It is suggested that there are active substances in the extracts, 
which is responsible for the decrease in blood pressure. It is well known that our body 
has multiple responses (e.g. baroreflex) to regulate the arterial blood pressure 
whenever it is deviated from normal. Arterial blood pressure regulation is important to 
provide cardiovascular function properly. The observed drop in BP and followed by 
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gradual recovery of blood pressure to normal value in rat after i.v injection is therefore 
an expected defense response. 
4.4.2 Pharmacological action of marine algal extracts 
In order to test if hypotensive effects of the algal extracts injected were due to 
the receptors that affect blood pressure, injection of algal extracts was carried out 
before and after the administration of the specific blocker. If the hypotensive effect of 
the extract is abolished after administration of the specific blocker, the extract is said 
to be mediated through that particular receptor. 
Histamine is stored and released primarily in mast cells and basophils. Foreign 
substances or drugs may stimulate the release of histamine (Brody et al., 1998). Its 
action on the cardiovascular system depends on stimulation of both histamine 1 and 
histamine 2 receptors, which cause vasodilation and fall in blood pressure. 
Pretreatment of pyrilamine and cimetidine simultaneously reduces the hypotensive 
effects of histamine in rats. This response was also observed when i.v injection of the 
aqueous extract of S. angustifolium after blockade of histamine 1 and histamine 2 
receptors, which may attenuate the hypotensive response. This indicates that the 
hypotensive response of the aqueous extract of S. angustifolium is mediated via 
histaminergic receptor. 
The hypotensive effect of the aqueous S. angustifolium was influenced by the 
pretreatment with propanolol. Propanolol is a nonselective beta-blocker which 
competitively inhibits the effects of catecholamines at (3i and Ps-adrenergic sites, 
1 5 2 
whether through endogenous stimulation with adrenaline or noradrenaline, or through 
exogenous stimulation with isoproterenol (Frishman, 1995). Isoproterenol is a potent 
(3-agonist. It reduces total peripheral resistance through p-receptor, resulting in 
considerable reduction in BP. Blockade of p-receptor with propanolol will abolish the 
effect of isoproterenol. The results suggested that hypotensive response of the aqueous 
extract ofS. angustifolium could be due to histaminergic and P-adrenergic mechanisms. 
However, the results also showed that the depressor effect on blood pressure of the 
叫ueous extract of angustifolium was independent on cholinergic and a-adrenergic, 
as well as autonomic ganglion systems, since pretreatment with blockers atropine (Fig. 
4.8), phentolamine (Fig. 4.6), and hexamethonium (Fig. 4.5) respectively could not 
attenuate the depressor response of the extract. 
The present data showed that the hypotensive effect of the methanol extract of 
5： angustifolium is mediated via a - and (3-adrenoceptor, autonomic ganglionic and 
histamine receptors, since the decrease of blood pressure induced by the methanol 
extract of S. angustifolium was significantly attenuated in the presence of 
phentolamine, propanolol, hexamethonium, pyrilamine and cimetidine, respectively. In 
addition，the cholinergic mechanism might also contribute to the hypotensive response 
of the methanol extract of S. angustifolium as the effect was significantly reduced if 
prior treatment of cholinergic blocker, atropine was given to the rats. It may therefore 
be suggested that, like acetylcholine, the methanol extract of S. angustifolium lowers 
the MAP of rat by activation of muscarinic M2 receptor on cardiac muscle, and also by 
vasodilation due to the indirect effects which it acts on vascular endothelial cells to 
release nitric oxide which relaxes smooth muscle (Rang and Dale, 1991). 
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The hypotensive effects induced by the methanol extract of S. siliquastrum 
might act through an activation of autonomic ganglion (Fig. 4.17) and P-adrenergic 
(Fig. 4.19) systems, since application of hexamethonium and propanolol blockers, 
respectively significantly attenuated the MAP of the rat. Hexamethonium is a ganglion 
blocker that selectively blocks ganglionic nicotinic receptors, causing a blockade of 
both sympathetic and parasympathetic nerves (Brody et al, 1998). Based on these 
findings, the hypotensive action of the methanol extract of siliquastrum seems to act 
on the autonomic nervous system. A fall in MAP of the methanol extract of S. 
siliquastrum was a result mainly from the blockade of sympathetic ganglia, which 
causes arteriolar vasodilation. The depressor effect of the methanol extract of S. 
siliquastrum was probably dependent on histaminergic receptor. Pretreatment with 
pyrilamine and cimetidine could significantly reduce the depressor effect of the 
methanol extract of S. siliquastrum in normotensive rat. In the presence of 
phentolamine and atropine, the MAP changes induced by the methanol extract of S. 
siliquastrum were not significantly affected, indicating that the hypotensive effect 
might not involve a-adrenergic and cholinergic receptor. 
The depressor response of the methanol extract of Enteromorpha sp. was 
attenuated by the pretreatment with phentolamine and hexamethonium. This indicated 
that the hypotensive effect was probably mediated through a-adrenergic (Fig. 4.24) 
and autonomic ganglion (Fig. 4.23) systems, respectively. Adrenergic transmission 
will be inhibited if autonomic ganglia are suppressed. Therefore, the depressor effect 
of Enteromorpha sp. via a-adrenergic was observed as well. The hypotensive effect is 
probably due to activation of sympathetic ganglia of autonomic nervous system. 
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However, these two agents could induce orthostatic hypotension, which could result 
from reduced cardiac output due to the decreased venous return and a blockade of 
baroreflex arch at autonomic ganglia level during orthostatic stress (Rang and Dale， 
1991). The hypotensive response to the methanol extract of Enteromorpha sp is 
apparently mediated through histaminergic receptor, since it is blocked by pyrilamine 
and cimetidine blockers (Fig. 4.27). The hypotensive effect of the methanol extract of 
Enteromorpha sp. is mediated neither v ia P-adrenergic nor cholinergic receptors 
because the application of the corresponding blockers failed to affect its hypotensive 
effect. 
Captopril is an orally active angiotensin-converting enzyme inhibitor. It is 
widely used in the treatment of hypertension. Angiotensin-convert ing enzyme (ACE) 
is responsible for converting of angiotensin I to angiotensin II，which is a potent 
vasoconstrictor that can increase peripheral resistance and raise blood pressure. A C E is 
also responsible for degradation of bradykinin, which is a powerful vasodilator 
peptides (Frishman, 1995). Therefore, inftision of captopril into the rat is expected to 
reduce the M A P response of angiotensin I (Fig. 4.28). The present study showed that 
the depressor response of all of the algal extracts was not reduced after infusion of 
captopril. For the methanol extract of S. angustifolium and Enteromorpha sp. they 
even potentiated the depressor response. Sham (1983) demonstrated that there was a 
significant potentiation of the depressor effect of bradykinin after captopril infusion 
due to the decrease in its breakdown. He also found that infusion of captopril could 
potentiate the depressor response of acacia extract. Accordingly, the depressor 
1 5 5 
response of the extract is bradykinin related. Therefore, the hypotensive effect of the 
algal extracts is related to kinin system rather than to the angiotensin system. 
Regarding the pharmacological studies, all of the blockers could not 
completely block the hypotensive effect of the marine algal extract. The hypotensive 
effects of the extracts were only partially blocked by the specified blockers. This could 
be explained by the fact that the hypotensive action of the extracts was mediated 
through more than one receptor. For example the aqueous extract of S. angustifolium, 
although P-adrenergic receptor was blocked by propranolol, the hypotensive response 
will still produce through histaminergic receptor. 
The aqueous and methanol extracts of marine algae might contain many active 
substances because they are only crude extract. These substances produced 
hypotensive response through different mechanisms of action. For the aqueous extract 
of angustifolium, the hypotensive responses were due to reduce sympathetic activity 
and cardiac output through p-adrenergic receptor, vasodilation of the smooth muscle 
through histaminergic receptor, and vasodilation cause by increased production of the 
prostaglandin through kinin system. Therefore, the aqueous extract of 5. angustifolium 
might be useful for people with high renin activity. 
For the methanol extract of S. angustifolium, the hypotensive effects were 
affected by at least 6 mechanisms. They were arteriolar vasodilation caused by 
blockade of sympathetic ganglia of the autonomic nervous system, via a - and (3-
adrenergic receptors caused by vasodilation and reduce cardiac output because of 
suppression of autonomic ganglion, decreased in heart rate and force of contraction 
through cholinergic receptor, and vasodilation through histaminergic receptors and 
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kinin system. This extract was probably suitable for the treatment of hypertensive 
emergencies, because blocking of autonomic ganglia will block both the sympathetic 
and parasympathetic ganglia resulting in a number of unwanted side effects. 
For the methanol extract of S. siliquastrum, the hypotensive responses were 
affected by arteriolar vasodilation caused by blockade of sympathetic ganglia and 
hence p-adrenergic receptor, and vasodilation caused by increased production of the 
prostaglandin via kinin system. For the methanol extract of Enteromorpha sp., the 
hypotensive responses were affected by arteriolar vasodilation caused by blockade of 
sympathetic ganglia and hence a-adrenoceptor, vasodilation of smooth muscle through 
histamine receptor, and kinin system. The methanol extract of Enteromorpha sp. is not 
suitable for people with postural hypotension because there would be a dramatic initial 
drop in blood pressure caused by blockade of a-adrenoceptor. 
Patients with mild hypertension usually start with one antihypertensive 
medication. However, sometimes blood pressure is not under control with one 
medication, and so combined antihypertensive medications are needed. By combining 
the actions of two different drugs, these medications are usually more effective in 
reducing both diastolic and systolic pressure，and could reduce the unpleasant effects 
because smaller doses are used. The present study found that all of the 4 extracts acted 
on different combination of receptors to exert their hypotensive responses. Therefore, 
they might be useful for patients who need antihypertensive drug combination. 
Furthermore, the results obtained demonstrated that the methanol extract of S. 
angustifolium which acted through 6 receptors did not produce the strongest 
hypotensive effect. In fact, the methanol extract of S, siliquastrum which acted on 3 
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receptors produced the strongest effect. It seems that the hypotensive response did not 
depend on the number of the receptors they acted on. 
It is known that blood pressure is determined by cardiac output and peripheral 
vascular resistance. However, the present results could not demonstrate which one is 
being affected to cause a decrease in MAP. Further investigation in in vitro studies is 
required to explain the mechanism of the algal extract in lowering the MAP. For 
example, using isolated rat mesenteric arteries, which is a resistance arteries important 
for the regulation of vascular resistance, to study the vasodilation effects of the drug, 
or using isolated rat atria to study the cardiac effects of the drug (Duarte et al., 2000). 
Concerning the chemical constituents of the crude aqueous and methanol 
extracts of algae contributing to the depressor of MAP in the rat, the aqueous extract 
seemed to contain many active substances to exert hypotensive action through 
different mechanisms of action. Active components in the methanol extract, however, 
might be due to the presence of phenolic substances since phenolic substances are 
commonly extracted from methanol. Chanh et al. (1988) demonstrated that the 
fractions isolated from the methanol extract of Lippia multiflora exhibited a marked 
and long lasting hypotensive effects for more than 15min in anaesthetized rats at 
0.2mg/kg. This active hypotensive substance was found to be a phenolic compound. 
Tannins are a group of plant polyphenols which are widely distributed in the bark and 
fruits of many plants. Calixto et al (1986) have shown that i.v infusion of tannic acid 
(O.lmg/kg to 3mg/kg) to anaesthetized rats led to a dose-dependent hypotensive 
activity that did not affect the heart rate. 
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The data obtained in the present study demonstrated that crude aqueous and 
methanol extracts of most marine algae tested were effective in lowering blood 
pressure in anaesthetized normotensive rats when administered via intravenous, except 
for both the extracts oi Hypnea charoides and the aqueous extract of Enteromorpha sp. 
The aqueous and methanol extracts of S. angustifolium and S. siliquastrum, and the 
methanol extract of Enteromorpha sp. showed a rapid and transient hypotensive effect 
and the blood pressure returned to the original level within a few minutes. The effect 
was due to a direct effect of algal extracts or its constituents. All of them induced a 
dose dependent decrease of BP except for the aqueous extract of S. siliquastrum, 
which produced tachyphylaxis. The aqueous extract of S. siliquastrum showed the 
strongest hypotensive activity among the algal extracts tested. However, it caused 
death in rat at a dose of 30mg/kg, probably due to the presence of toxic substance(s). 
From the above pharmacological studies, the hypotensive effect of the aqueous 
extract of S. angustifolium seemed to be mediated through p-adrenergic and 
histaminergic receptors, and probably kinin system, while the effect of methanol 
extract of angustifolium appeared to be mediated via all the receptors tested as well 
as kinin system. For the methanol extract of S. siliquastrum, its hypotensive effect was 
probably mediated through P-adrenoceptor, autonomic-ganglion and kinin system, 
whereas the effects of the methanol extract of Enteromorpha sp. might involve a -
adrenoceptor，autonomic ganglion, histaminergic receptor and kinin system. 
Nevertheless, further studies including pharmacological in vitro study, and purification 
of active substances are necessary in order to elucidate the mechanisms of the 
cardiovascular action of the seaweed extracts. 
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CHAPTER 5 
CONCLUSION 
Marine algae have been used since ancient time as a source of human and 
animal food, and fertilizer. Recently, there is an increasing interest in the use of 
marine algae as a natural source to discover the safer and novel compounds with 
potent biological activities. 
The present study demonstrated that the aqueous and methanol extracts of 
marine algae exhibited multiple antioxidant effects. The aqueous extracts of marine 
algae were found to have higher superoxide radical scavenging activity than that of 
their methanol extracts. Both extracts were found to be an effective scavenger of 
peroxyl radicals initiated by AAPH that will cause lysis of the membrane of the RBC. 
Both extracts also showed strong inhibition of Fe^Vascorbate induced lipid 
peroxidation. In hemolysis and lipid peroxidation assays, the methanol extracts or 
seaweed showed a greater ability to protect RBC and inhibit lipid peroxidation than 
that of the aqueous extracts. The ability of both extracts to inhibit hemolysis did not 
correlate well with their ability to suppress lipid peroxidation. This might be due to 
the fact that they involved slightly different mechanisms and also that both extracts 
might contain different active components to act at different sites. Among the 13 
species examined, the methanol extract of S. siliquastrum showed the most excellent 
antioxidant activity against lipid peroxidation and hemolysis. 
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The chemical components in the methanol extract of S. siliquastrum was 
further isolated by 4 different solvents and one of the fraction, the dichloromethane 
fraction was separated by column chromatography to produce 4 sub-fractions (Fl , F2, 
F3 and F4). All of the 4 sub-fractions exhibited a marked antioxidant activity. Sub-
fractions 1，3 and 4 were found to be more efficient than that of BHA in the inhibition 
of lipid peroxidation. However, all of the sub-fractions were effective to protect RBC 
against hemolysis, and were significantly more efficient than that of BHA and vitamin 
C in terms of inhibition of hemolysis. But F3 and F4 could cause hemolysis to cells at 
high concentration. All sub-fractions showed moderate superoxide radical scavenging 
activities. According to TLC analysis, F l and F3 contained one phenolic compound 
with reducing properties, while F4 contained two such compounds. Based on IR 
spectrum, hydroxyl group(s) and aromatic ring were present in these sub-fractions, 
indicating the presence of phenolic compounds. Therefore, at least 4 types of phenolic 
compounds were identified from S. siliquastrum with strong antioxidant activity. 
There was no correlation between the antioxidant effectiveness of the sub-fractions 
and their total phenolic contents. F l showed the highest potency of antioxidant effects 
but its total phenolic content was not the highest. This was probably due to some 
interfering substances such as ascorbic acid or sugar present in the extracts. 
Overall, as shown in both the lipid peroxidation and hemolysis assays, F l 
contained the most potent phenolic compound which is a non-polar and non-toxic 
chain-breaking antioxidant. This active component may be useful in the treatment of 
disease states associated with free radical production and lipid peroxidation. 
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Only 4 species of marine algae, namely S. angustifolium, S. siliquastrum, H. 
charoides and Enteromorpha sp. were studied for their hypotensive effects in rats. 
The present study showed that the aqueous and methanol extracts of S. angustifolium 
and S. siliquastrum, and the methanol extract of Enteromorpha sp. produced a fall in 
blood pressure in normotensive rats. These extracts elicited immediate and transient 
hypotensive responses ( � 3 0 s e c ) , followed by a gradual recovery to the original level 
within 6 min. This indicated a direct effect of the extracts on the cardiovascular 
system. Among the 4 marine algae, the aqueous extract of S. siliquastrum was the 
most potent hypotensive agent with an ED50 of 0.6mg/kg. However, it produced 
tachyphylaxis and killed the rats when the dosage of i.v injection reached 30mg/kg 
dose. 
Based on the pharmacological studies, the hypotensive effect of the aqueous 
extract of S, angustifolim was probably mediated through p-adrenergic and 
histaminergic receptors, as well as the kinin system, while the effects of methanol 
extract of S. angustifolium appeared to be mediated via all the receptors tested. The 
hypotensive effect of the methanol extract of S. siliquastrum might involve p -
adrenoceptor, autonomic-ganglion and kinin system, while the effects of methanol 
extract of Enteromorpha sp. seems to be mediated via a-adrenoceptor , autonomic-
ganglion, histaminergic receptor and kinin system. Further studies on in vitro studies 
are required to explain the mechanism(s) of the algal extracts in lowering the mean 
arterial pressure. 
1 6 2 
It is evident that hypertension in spontaneous hypertensive rat and humans are 
considered as "free radical-dependent disease" (Kumar and Das, 1993). There was an 
increase in the production of superoxide anion and hydrogen peroxide in uncontrolled 
essential hypertension compared with normal controls. The results of the present study 
demonstrated that marine algae extracts contained active antioxidative compounds, 
which were effective to protect cells against hemolysis by peroxyl radicals and 
inhibited iron-induced lipid peroxidation. In addition, it could also produce a 
hypotensive response in anesthetized normotensive rats. Therefore, it is possible to 
say that one of the reasons the marine algal extracts produce a decrease in blood 
pressure could be due to a reduction of free radicals produced during metabolic 
processes. Nitric oxide that is involved in regulating vascular tone and in inducing the 
relaxation of smooth muscle cells would function normally in the absence of free 
radicals, hence the blood pressure would be normal. Epidemiological studies revealed 
that high intakes of antioxidants e.g. vitamin E, is associated with a significant 
reduction in the risk of cardiovascular heart disease (Maxwell and Lip, 1997). 
Therefore, marine algae may be useful in the treatment of various diseases which are 
associated with free radicals. However, further studies using isolated rat mesenteric 
arteries and rat atria are needed to better understand the mechanisms of the seaweed 
extracts in decreasing blood pressure. 
Further research on the mechanisms of the antioxidant effects of seaweed 
extracts is needed. For example, in vitro studies by measuring the inhibition of low-
density lipoprotein (LDL) oxidation and liposome oxidation. These models are 
suggested because LDL oxidation is an early event in coronary disease and liposome 
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oxidation is relevant to oxidation in food systems. To better understand chemical 
identity of the active phenolic antioxidant components, additional analytical 
procedures such as HPLC, GC/MS as well as LC/MS using authentic phenolic 
standards are needed. 
The present study found that the marine algae have potential for their 
pharmaceutical applications. They have antioxidant activity which could protect cells 
and prevent lipid peroxidation, as well as hypotensive activity. Besides they may be 
useful in food industry as antioxidant to retard and extend the shelf life of foods. 
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